{"meta":{"query_hash":"11ddc1b80af9","filters":{"venue":"Diabetes Therapy"},"cohort_total":80,"direct_labels_cover":0,"predictions_cover":80,"exported":80,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/11ddc1b80af9","api":"https://metacan.xera.ac/api/v1/cohort?venue=Diabetes+Therapy"},"results":[{"id":"W1974658403","doi":"10.1007/s13300-014-0080-0","title":"Cost–Utility Analysis of Glucagon-Like Peptide-1 Agonists Compared with Dipeptidyl Peptidase-4 Inhibitors or Neutral Protamine Hagedorn Basal Insulin as Add-On to Metformin in Type 2 Diabetes in Sweden","year":2014,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Lunds Universitet; Vetenskapsrådet; Novo Nordisk; Sanofi; Eli Lilly and Company","keywords":"Medicine; Metformin; Internal medicine; Endocrinology; Sitagliptin; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus","score_opus":0.03225883259212647,"score_gpt":0.29655709969669153,"score_spread":0.26429826710456505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974658403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838606,0.005827371,0.0049811904,0.0006540683,0.00008127852,0.00036741485,0.0020175949,0.000064490654,0.0021459905],"genre_scores_gemma":[0.9970381,0.00077994727,0.0010780874,0.000075846234,0.0000135583505,0.00012564377,0.000531701,0.00001024907,0.0003467988],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9957789,0.0033643064,0.00012902837,0.00020704884,0.0002240656,0.00029658378],"domain_scores_gemma":[0.9847532,0.013012793,0.0010299234,0.00030315985,0.00044405708,0.00045687324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076043583,0.001765041,0.0025703034,0.0021311247,0.00023690186,0.0021663536,0.0012794494,0.0013756944,0.0033121584],"category_scores_gemma":[0.018320458,0.0010628459,0.0060933237,0.0011568541,0.00066620717,0.001138341,0.0011716618,0.0014930548,0.00019335176],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018458521,0.0005592357,0.016417596,0.0011321527,0.0045672944,0.0005854129,0.00008549719,0.94539,0.0006115642,0.0020830715,0.00082370144,0.009285958],"study_design_scores_gemma":[0.0043465164,0.008406974,0.032632224,0.00087827246,0.010013007,0.00078739657,0.00035969782,0.93537295,0.0012293473,0.0041458965,0.0016361154,0.00019166959],"about_ca_topic_score_codex":0.012530185,"about_ca_topic_score_gemma":0.0040876814,"teacher_disagreement_score":0.012530185,"about_ca_system_score_codex":0.0052338047,"about_ca_system_score_gemma":0.0024699382,"threshold_uncertainty_score":0.040216208},"labels":[],"label_agreement":null},{"id":"W2023859994","doi":"10.1007/s13300-012-0013-8","title":"Efficacy and Safety of Taspoglutide Versus Sitagliptin for Type 2 Diabetes Mellitus (T-Emerge 4 Trial)","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"F. Hoffmann-La Roche","keywords":"Sitagliptin; Medicine; Placebo; Metformin; Internal medicine; Sitagliptin Phosphate; Clinical endpoint; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Randomized controlled trial; Endocrinology","score_opus":0.043983561132298676,"score_gpt":0.3092227144635877,"score_spread":0.265239153331289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023859994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880042,0.0064419536,0.00041804055,0.0006942351,0.00033527883,0.0009422364,0.0010960686,0.00009677492,0.0019712348],"genre_scores_gemma":[0.98807913,0.0033816895,0.0011494443,0.0008544593,0.00050327403,0.0018208527,0.0018366518,0.000019841817,0.0023547334],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9996258,0.0002256697,0.000027461485,0.000057795547,0.000027144499,0.00003610219],"domain_scores_gemma":[0.9994252,0.00016692521,0.00018168875,0.000031285213,0.000031813965,0.00016310801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016403454,0.0010495231,0.0024048337,0.00022032573,0.00025578833,0.00076380384,0.00066200556,0.0009827431,0.006638868],"category_scores_gemma":[0.0012624797,0.00036580444,0.0019049656,0.00022485628,0.00055609125,0.0006369827,0.00033447272,0.0020819968,0.000693355],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98258764,0.0014946698,0.00088879967,0.0005707945,0.00096208806,0.000037116126,0.000025705274,0.0002436835,0.0018740746,0.00006862772,0.0006867784,0.010560024],"study_design_scores_gemma":[0.95082545,0.0436741,0.0030355603,0.00004459179,0.0010119866,0.000052239036,0.000017026008,0.00035992006,0.0003561294,0.00010392124,0.0005092049,0.0000098997125],"about_ca_topic_score_codex":0.0005912281,"about_ca_topic_score_gemma":0.0012638603,"teacher_disagreement_score":0.006638868,"about_ca_system_score_codex":0.00046321977,"about_ca_system_score_gemma":0.0007069221,"threshold_uncertainty_score":0.022209167},"labels":[],"label_agreement":null},{"id":"W2041650397","doi":"10.1007/s13300-014-0065-z","title":"Early Discontinuation and Restart of Insulin in the Treatment of Type 2 Diabetes Mellitus","year":2014,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Discontinuation; Diabetes mellitus; Insulin; Type 2 Diabetes Mellitus; Type 2 diabetes; Internal medicine; Intensive care medicine; Endocrinology","score_opus":0.022515987662305347,"score_gpt":0.2845708432846278,"score_spread":0.26205485562232245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041650397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98896563,0.008749992,0.00036388406,0.0006379367,0.000034210534,0.00001744348,0.00023344305,0.000010620573,0.0009868555],"genre_scores_gemma":[0.9966917,0.0023732488,0.00034841773,0.00012346244,0.00007404522,0.000009618533,0.00022006495,0.0000029405035,0.00015644787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989537,0.0004497555,0.00012960353,0.00007404784,0.00028683466,0.00010604617],"domain_scores_gemma":[0.9924941,0.002766884,0.003889673,0.00010887945,0.00025957564,0.00048082127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014900274,0.00024977466,0.00038924153,0.000698104,0.0002922216,0.00082348817,0.0003319245,0.00035366003,0.0010826626],"category_scores_gemma":[0.0060754027,0.00013850439,0.000726867,0.0010712394,0.00019835793,0.00036021194,0.00037449793,0.0009071675,0.00008732362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004873961,0.00012066518,0.97687554,0.00007459603,0.00012535555,0.00016979394,0.00004409316,0.00028811255,0.00010612379,0.000037623668,0.00015945979,0.021511232],"study_design_scores_gemma":[0.000021127362,0.00030159176,0.9967976,0.000101487094,0.00011713152,0.0006907512,0.000077297635,0.0011358669,0.00010149164,0.00010138407,0.0005478879,0.000006224063],"about_ca_topic_score_codex":0.0031225646,"about_ca_topic_score_gemma":0.0045204577,"teacher_disagreement_score":0.0031225646,"about_ca_system_score_codex":0.0005643223,"about_ca_system_score_gemma":0.00074625184,"threshold_uncertainty_score":0.007880092},"labels":[],"label_agreement":null},{"id":"W2060423751","doi":"10.1007/s13300-012-0007-6","title":"Cost of Self-Monitoring of Blood Glucose in Canada among Patients on an Insulin Regimen for Diabetes","year":2012,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Medicine; Diabetes mellitus; Insulin; Regimen; Pharmacy; Type 2 diabetes; Medical prescription; Diabetes management; Internal medicine; Intensive care medicine; Emergency medicine; Endocrinology; Pharmacology; Family medicine","score_opus":0.018317023433571805,"score_gpt":0.2594698090616091,"score_spread":0.2411527856280373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060423751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866833,0.0008753082,0.00006193808,0.00044565275,0.0000116929,0.00007047512,0.0099884905,0.000010294189,0.0018528763],"genre_scores_gemma":[0.9937115,0.000909433,0.00020471973,0.00016516482,0.00001586822,0.000022417207,0.0045223027,0.0000031632676,0.00044557903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990508,0.00007147032,0.00008595714,0.00010377926,0.00045412863,0.00023385948],"domain_scores_gemma":[0.9976926,0.00015715405,0.0010738876,0.000052647945,0.0005800679,0.00044371345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036836203,0.00023597061,0.0002975125,0.0012000301,0.0012164215,0.0011701973,0.0009684307,0.00037326894,0.001801503],"category_scores_gemma":[0.0025548488,0.0003073235,0.0006410277,0.0036552798,0.0003106727,0.00032781926,0.0006150148,0.00069271366,0.00012522975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010677955,0.000042193544,0.99469733,0.00003865404,0.000070843074,0.00010205411,0.00005312595,0.00025130258,0.000046589135,0.000060967202,0.0009626617,0.0035675054],"study_design_scores_gemma":[0.0000143437355,0.00003216936,0.99824643,0.000034878503,0.000046143363,0.0001376738,0.00015668011,0.0008400992,0.000031345913,0.00002305979,0.0004308999,0.0000062245495],"about_ca_topic_score_codex":0.9585699,"about_ca_topic_score_gemma":0.9668583,"teacher_disagreement_score":0.041430116,"about_ca_system_score_codex":0.022098362,"about_ca_system_score_gemma":0.015361353,"threshold_uncertainty_score":0.1603356},"labels":[],"label_agreement":null},{"id":"W2129617225","doi":"10.1007/s13300-015-0118-y","title":"Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis","year":2015,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Glycemic; Depression (economics); Distress; Internal medicine; Diabetes mellitus; Glycated hemoglobin; Observational study; Type 2 diabetes; Confounding; Mood; Post-hoc analysis; Patient Health Questionnaire; Psychiatry; Insulin; Endocrinology; Clinical psychology; Depressive symptoms","score_opus":0.02949611979113506,"score_gpt":0.31268760597105916,"score_spread":0.28319148617992407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129617225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987551,0.00008419909,0.00038404085,0.00002035507,0.000010756475,0.000098845296,0.00046497938,0.00001026998,0.00017140582],"genre_scores_gemma":[0.9976126,0.00002995827,0.0008175441,0.000021236425,0.000020184048,0.0002956874,0.0009272049,0.000008576347,0.0002669642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99589276,0.0022737563,0.0002693694,0.00062622025,0.00050375157,0.00043411728],"domain_scores_gemma":[0.9886602,0.007466086,0.0013588314,0.0009892321,0.0006640566,0.0008617044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005320067,0.0011452017,0.0012067311,0.0011606833,0.0005354556,0.00089530885,0.0010461495,0.0005551261,0.0030965481],"category_scores_gemma":[0.008171921,0.00042447046,0.0026237958,0.0008534985,0.00074049964,0.0007489613,0.00097171817,0.0010502457,0.00028425033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024459474,0.0022163459,0.9571854,0.00019501937,0.0039824205,0.00038679107,0.0005833786,0.0006821291,0.0031334874,0.000104377585,0.00059014914,0.0064810757],"study_design_scores_gemma":[0.00062242034,0.018745469,0.97405934,0.000020532281,0.0014391248,0.00023572109,0.0003948489,0.0026985072,0.0012881851,0.00008275788,0.00038565628,0.00002751204],"about_ca_topic_score_codex":0.0014532178,"about_ca_topic_score_gemma":0.0012723834,"teacher_disagreement_score":0.005320067,"about_ca_system_score_codex":0.00047125615,"about_ca_system_score_gemma":0.0010138056,"threshold_uncertainty_score":0.028135538},"labels":[],"label_agreement":null},{"id":"W2172438155","doi":"10.1007/s13300-015-0142-y","title":"IDegLira Versus Alternative Intensification Strategies in Patients with Type 2 Diabetes Inadequately Controlled on Basal Insulin Therapy","year":2015,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Novo Nordisk Fonden; Novo Nordisk","keywords":"Medicine; Liraglutide; Insulin glargine; Insulin degludec; Type 2 diabetes; Insulin aspart; Hypoglycemia; Internal medicine; Insulin; Glycated hemoglobin; Lixisenatide; Diabetes mellitus; Glucagon-like peptide 1 receptor; Endocrinology; Agonist","score_opus":0.04309277245387194,"score_gpt":0.2779275746307542,"score_spread":0.23483480217688224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2172438155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90619457,0.08912746,0.0012490988,0.00032986433,0.00029477553,0.0007977241,0.00042753512,0.000039185958,0.0015397373],"genre_scores_gemma":[0.9873043,0.009842343,0.0011781708,0.00038177444,0.00018427317,0.0003398658,0.00043918067,0.000009173993,0.00032087034],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99552476,0.0031381936,0.00058464037,0.00035617396,0.00021222165,0.0001840818],"domain_scores_gemma":[0.9969818,0.0018559478,0.00067135587,0.0001916211,0.000104651306,0.0001945012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0082057845,0.0010137405,0.004941829,0.0007257316,0.00017575546,0.0013732127,0.0005232121,0.0009816398,0.0017112764],"category_scores_gemma":[0.006736759,0.0005497286,0.008492001,0.000715635,0.00041487,0.00091482676,0.00057307014,0.0015873195,0.00017006023],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8811952,0.0012042951,0.009287653,0.0052886805,0.04374362,0.00010454973,0.000093047536,0.0013992555,0.0013866508,0.00016558499,0.00021054008,0.055920895],"study_design_scores_gemma":[0.5175896,0.24484603,0.07161161,0.0025107865,0.15066046,0.00032676745,0.0003209485,0.0057890816,0.001746924,0.0015315224,0.0029471542,0.00011915002],"about_ca_topic_score_codex":0.000700639,"about_ca_topic_score_gemma":0.0021582977,"teacher_disagreement_score":0.0082057845,"about_ca_system_score_codex":0.00063318334,"about_ca_system_score_gemma":0.00079952343,"threshold_uncertainty_score":0.04339689},"labels":[],"label_agreement":null},{"id":"W2276028032","doi":"10.1007/s13300-016-0155-1","title":"A Network Meta-analysis Comparing Exenatide Once Weekly with Other GLP-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sheridan College; Public Health Ontario","funders":"AstraZeneca","keywords":"Exenatide; Medicine; Lixisenatide; Tolerability; Dulaglutide; Metformin; Liraglutide; Internal medicine; Type 2 diabetes; Glycated hemoglobin; Glucagon-like peptide 1 receptor; Discontinuation; Type 2 Diabetes Mellitus; Pharmacology; Diabetes mellitus; Adverse effect; Endocrinology; Agonist; Insulin; Receptor","score_opus":0.1266099849112865,"score_gpt":0.3423086737592977,"score_spread":0.2156986888480112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276028032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055974673,0.9282539,0.0059527447,0.0014075252,0.0011744308,0.0010693182,0.00421669,0.00023963356,0.0017112312],"genre_scores_gemma":[0.819625,0.16276938,0.0074949367,0.0018155884,0.00060041,0.0026291306,0.0037589348,0.000113426126,0.0011932098],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9769283,0.016838573,0.00226958,0.0022791787,0.0012381427,0.0004462241],"domain_scores_gemma":[0.972263,0.022983193,0.0024212387,0.0009383184,0.0010033515,0.00039089553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020545878,0.0033038745,0.01641982,0.0053262254,0.00068980746,0.0031158896,0.0022147885,0.0026600535,0.005323919],"category_scores_gemma":[0.03724449,0.0013967695,0.059376255,0.005677782,0.0006194805,0.0018986805,0.0015421147,0.0029541266,0.00036444917],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0082739135,0.00004137353,0.005020826,0.034232948,0.94503236,0.00010597574,0.000026252557,0.002381626,0.00014804439,0.00012890206,0.0005738452,0.0040339064],"study_design_scores_gemma":[0.0023146567,0.00033025592,0.0028609235,0.0018084119,0.9901984,0.000049192666,0.000013876805,0.0014756443,0.000058518886,0.0002970647,0.0005738142,0.000019254281],"about_ca_topic_score_codex":0.009423213,"about_ca_topic_score_gemma":0.010719648,"teacher_disagreement_score":0.020545878,"about_ca_system_score_codex":0.0023506281,"about_ca_system_score_gemma":0.0023250764,"threshold_uncertainty_score":0.108658314},"labels":[],"label_agreement":null},{"id":"W2299595115","doi":"10.1007/s13300-016-0163-1","title":"Simultaneous Reduction in Both HbA1c and Body Weight with Canagliflozin Versus Glimepiride in Patients with Type 2 Diabetes on Metformin","year":2016,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Janssen Research and Development","keywords":"Canagliflozin; Glimepiride; Medicine; Metformin; Glycemic; Hypoglycemia; Type 2 diabetes; Diabetes mellitus; Adverse effect; Internal medicine; Urology; Weight loss; Endocrinology; Gastroenterology; Obesity","score_opus":0.006691807101830577,"score_gpt":0.21757832562927343,"score_spread":0.21088651852744286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2299595115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969214,0.0021127337,0.00014995906,0.00007734329,0.000049471808,0.000115653376,0.000075640375,0.000008417818,0.0004895447],"genre_scores_gemma":[0.99789065,0.0009086013,0.0004909831,0.00017166707,0.000087585446,0.00013115421,0.00014564778,0.000002665234,0.0001711076],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9993574,0.00029701806,0.00008894538,0.00008993722,0.0001092035,0.000057406207],"domain_scores_gemma":[0.9993017,0.00025498404,0.00016002743,0.00004462228,0.000043925862,0.00019480435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019336279,0.00036730774,0.0016146171,0.00039584658,0.00021182052,0.00056943495,0.0002532923,0.00035093873,0.0013196686],"category_scores_gemma":[0.0016594029,0.00023834052,0.0013508783,0.0003298702,0.00022937283,0.0004412912,0.00026114698,0.00078845664,0.00013901936],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7879596,0.0077489926,0.05140051,0.0006906888,0.0036768345,0.00014285775,0.00015188198,0.0012927674,0.014527979,0.000077366865,0.0005749283,0.13175555],"study_design_scores_gemma":[0.20826033,0.45302042,0.31800285,0.00020662553,0.005852528,0.0004712942,0.00019839559,0.0036523174,0.007443781,0.00025578483,0.0025724517,0.00006332562],"about_ca_topic_score_codex":0.0004271464,"about_ca_topic_score_gemma":0.0011133326,"teacher_disagreement_score":0.0019336279,"about_ca_system_score_codex":0.00033347358,"about_ca_system_score_gemma":0.0006303834,"threshold_uncertainty_score":0.0102261305},"labels":[],"label_agreement":null},{"id":"W2320992886","doi":"10.1007/s13300-016-0166-y","title":"Clinical Effectiveness and Safety of Analog Glargine in Type 1 Diabetes: A Systematic Review and Meta-Analysis","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Conselho Nacional de Desenvolvimento Científico e Tecnológico; Academy of Medical Sciences","keywords":"Medicine; Meta-analysis; Type 2 diabetes; Insulin glargine; Diabetes mellitus; Systematic review; Intensive care medicine; MEDLINE; Pharmacology; Internal medicine; Endocrinology","score_opus":0.10504614652268317,"score_gpt":0.43005059029307335,"score_spread":0.3250044437703902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320992886","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003882854,0.99475324,0.00042777474,0.00012941622,0.00011051235,0.0002805831,0.00023973468,0.00001590265,0.00016004198],"genre_scores_gemma":[0.1779354,0.816011,0.0025561308,0.0008012912,0.00032461903,0.0014755403,0.0005989558,0.000027159987,0.0002698781],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9865348,0.007030061,0.003535014,0.001121784,0.0014586969,0.00031964207],"domain_scores_gemma":[0.97513753,0.01884057,0.0036780771,0.0006165057,0.0014463379,0.00028094978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01760326,0.0029744275,0.022808332,0.0072659897,0.0006000397,0.0036074708,0.002181482,0.002532495,0.0034896338],"category_scores_gemma":[0.036666695,0.0014370361,0.0447842,0.006889909,0.0009016968,0.0018809572,0.0014188273,0.0019383646,0.00023976411],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021251182,0.000032678752,0.0024445883,0.362728,0.6220168,0.0000919281,0.000063720894,0.00053661066,0.00013833288,0.00011119293,0.00030037426,0.0094107045],"study_design_scores_gemma":[0.00055180676,0.00019589563,0.002006708,0.02229636,0.9736404,0.000069849404,0.000031120955,0.00018581141,0.00008054121,0.00013213186,0.0007908244,0.000018624989],"about_ca_topic_score_codex":0.005167248,"about_ca_topic_score_gemma":0.00886219,"teacher_disagreement_score":0.022808332,"about_ca_system_score_codex":0.003133796,"about_ca_system_score_gemma":0.0037054305,"threshold_uncertainty_score":0.09309608},"labels":[],"label_agreement":null},{"id":"W2567557402","doi":"10.1007/s13300-016-0220-9","title":"Lack of Evidence to Guide Deprescribing of Antihyperglycemics: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Waterloo; Women's College Hospital; University of Toronto; Ottawa Hospital; University of Ottawa; Bruyère","funders":"Canadian Institutes of Health Research","keywords":"Deprescribing; Medicine; MEDLINE; Type 2 diabetes; Glycemic; Cochrane Library; Hypoglycemia; CINAHL; Glycated hemoglobin; Polypharmacy; Adverse effect; Intensive care medicine; Systematic review; Diabetes mellitus; Meta-analysis; Nursing; Internal medicine; Psychological intervention","score_opus":0.23377379864574205,"score_gpt":0.4214522913955017,"score_spread":0.18767849274975967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2567557402","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007935258,0.9960532,0.00034689694,0.0010473407,0.00020678535,0.00076773093,0.00039869713,0.000015134807,0.00037064197],"genre_scores_gemma":[0.024019912,0.9693402,0.0021610972,0.002164578,0.00018300982,0.0016156838,0.00034332115,0.000015111072,0.00015705173],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9727622,0.00952375,0.010678007,0.0016408098,0.004918938,0.00047630584],"domain_scores_gemma":[0.8715948,0.095382914,0.02086391,0.0016039236,0.00949168,0.0010628024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031098654,0.0018381,0.011946562,0.014421709,0.0010418746,0.0051077767,0.003769967,0.0036054116,0.0056147627],"category_scores_gemma":[0.1540165,0.00218063,0.009387604,0.0126506165,0.0019446395,0.0058663227,0.0023583767,0.0023886156,0.00052089395],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000108995366,0.000009145847,0.00052925316,0.97097296,0.007209934,0.00004857918,0.00015366162,0.0000517781,0.000051954292,0.00018131164,0.0011534448,0.019529087],"study_design_scores_gemma":[0.0002106687,0.0000623514,0.0014641943,0.949285,0.04084092,0.00011967536,0.00018777241,0.00007148404,0.00007882503,0.00033034902,0.0073245787,0.000024256871],"about_ca_topic_score_codex":0.012218171,"about_ca_topic_score_gemma":0.035726756,"teacher_disagreement_score":0.031098654,"about_ca_system_score_codex":0.007839679,"about_ca_system_score_gemma":0.021698553,"threshold_uncertainty_score":0.16446733},"labels":[],"label_agreement":null},{"id":"W2589084718","doi":"10.1007/s13300-017-0232-0","title":"Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials","year":2017,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Magnesium in Health and Disease","field":"Nursing","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"European Association for the Study of Diabetes; Mitsubishi Tanabe Pharma Corporation; Canada Research Chairs; European Foundation for the Study of Diabetes; AstraZeneca; Janssen Scientific Affairs; American Diabetes Association","keywords":"Canagliflozin; Medicine; Post-hoc analysis; Internal medicine; Magnesium; Placebo; Gastroenterology; Diabetes mellitus; Type 2 diabetes; Endocrinology; Type 2 Diabetes Mellitus; Randomized controlled trial; Hypermagnesemia; Hypomagnesemia; Chemistry; Pathology","score_opus":0.008613324038143825,"score_gpt":0.27048372605943427,"score_spread":0.26187040202129047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2589084718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6377032,0.29707864,0.013770469,0.0029934382,0.0062417295,0.025096506,0.008944843,0.0006927851,0.0074783843],"genre_scores_gemma":[0.9492317,0.022580769,0.008405283,0.0015858598,0.0014129764,0.01272693,0.002379338,0.000113929724,0.001563114],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9743532,0.01836103,0.002720687,0.001882296,0.0020040092,0.00067877397],"domain_scores_gemma":[0.9628721,0.026490156,0.0063024675,0.001903214,0.0017846127,0.00064743584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028702984,0.0018128295,0.008410543,0.001274787,0.0004262804,0.0020993373,0.0010004658,0.0013007815,0.005020683],"category_scores_gemma":[0.038343944,0.00061640143,0.014079802,0.0014819023,0.0007989187,0.001123656,0.0006481833,0.0017458119,0.00029952324],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.707974,0.00058075145,0.0057782573,0.018473025,0.23653562,0.000102480175,0.00006324251,0.0007703684,0.0011460802,0.00020177301,0.0016796123,0.026694715],"study_design_scores_gemma":[0.5858743,0.03689781,0.027753476,0.002385309,0.3361864,0.00018308246,0.00009168683,0.002643695,0.0015688104,0.0009951321,0.0053108926,0.000109375156],"about_ca_topic_score_codex":0.0005498986,"about_ca_topic_score_gemma":0.0011637422,"teacher_disagreement_score":0.028702984,"about_ca_system_score_codex":0.0011523728,"about_ca_system_score_gemma":0.0016505646,"threshold_uncertainty_score":0.15179771},"labels":[],"label_agreement":null},{"id":"W2788976924","doi":"10.1007/s13300-018-0375-7","title":"Insulin Matters: A Practical Approach to Basal Insulin Management in Type 2 Diabetes","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Dalhousie University; Centre for Family Medicine; Horizon Health Network; Island Health; Lakeshore General Hospital; University of Toronto; Western University; St. Michael's Hospital; Trillium Health Centre; Saint John Regional Hospital; LMC Diabetes & Endocrinology (Canada); Alberta Health Services; Nova Scotia Health Authority; Credit Valley Hospital; Health Sciences Centre; McMaster University; Winnipeg Regional Health Authority","funders":"Sanofi","keywords":"Medicine; Type 2 diabetes; Prediabetes; Glycemic; Diabetes mellitus; Intensive care medicine; Insulin resistance; Diabetes management; Nephropathy; Endocrinology","score_opus":0.04182465527090936,"score_gpt":0.3330721675094244,"score_spread":0.2912475122385151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2788976924","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00048975524,0.10062661,0.01031103,0.823767,0.038035497,0.00024780986,0.00014566894,0.00041472493,0.025961952],"genre_scores_gemma":[0.015574011,0.25175053,0.0829497,0.55726564,0.06250817,0.0005529974,0.00046286036,0.00034763737,0.02858847],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98966914,0.0036881098,0.001185727,0.00045181913,0.004524182,0.00048099516],"domain_scores_gemma":[0.9830183,0.0039136303,0.0008853189,0.0005160025,0.008886398,0.0027803693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013777102,0.0015596375,0.0013514697,0.0026947164,0.0031109257,0.006146336,0.0036404238,0.008526632,0.0074536344],"category_scores_gemma":[0.03109453,0.00070199574,0.0013080069,0.0020364937,0.005022396,0.0054586097,0.0040694727,0.02214598,0.006462963],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054372962,0.00009654834,0.00059622363,0.0011284195,0.000046070018,0.00043729445,0.0005010554,0.00020578131,0.0002514358,0.0058975336,0.68242323,0.30836204],"study_design_scores_gemma":[0.000058784673,0.00007874875,0.0012721459,0.0048356685,0.000049722516,0.00054489874,0.00075726194,0.00018128673,0.0001262149,0.010313471,0.9817271,0.00005462372],"about_ca_topic_score_codex":0.044910055,"about_ca_topic_score_gemma":0.1342524,"teacher_disagreement_score":0.044910055,"about_ca_system_score_codex":0.0068764435,"about_ca_system_score_gemma":0.022570243,"threshold_uncertainty_score":0.089297295},"labels":[],"label_agreement":null},{"id":"W2807496383","doi":"10.1007/s13300-018-0448-7","title":"Successful Management of Poorly Controlled Type 2 Diabetes with Multidisciplinary Neurobehavioral Rehabilitation: A Case Report and Review","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Type 2 diabetes; Rehabilitation; Glycemic; Diabetes mellitus; Depression (economics); Type 2 Diabetes Mellitus; Anxiety; Physical therapy; Intensive care medicine; Psychiatry; Endocrinology","score_opus":0.015083075822666143,"score_gpt":0.29526393161513165,"score_spread":0.2801808557924655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2807496383","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010025155,0.98178583,0.002107589,0.0012730696,0.00068310736,0.00006174619,0.00004341078,0.000041811727,0.003978227],"genre_scores_gemma":[0.06385902,0.9289782,0.0027826317,0.001519051,0.0017099669,0.000058231613,0.000110818575,0.000016670023,0.0009654023],"study_design_codex":"design_other","study_design_gemma":"case_report","domain_scores_codex":[0.9995158,0.00007166114,0.00018218326,0.00008422707,0.00008824834,0.000057899622],"domain_scores_gemma":[0.99937797,0.000283152,0.0001757829,0.000025586838,0.000067497705,0.00007002084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040901673,0.0011540597,0.0011534387,0.0030808833,0.0006770406,0.0011624288,0.0014818395,0.0023983778,0.0011517407],"category_scores_gemma":[0.0014859367,0.0003222045,0.000671988,0.0028280967,0.0008547666,0.001464336,0.0006582067,0.0012595605,0.00074702036],"study_design_candidate":"case_report","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114879,0.00036505403,0.008426538,0.01910451,0.00030248205,0.42563185,0.0009803068,0.00086284615,0.0030516875,0.0020726772,0.021577148,0.51751006],"study_design_scores_gemma":[0.000019386738,0.000112401205,0.004982741,0.0037533338,0.00021044759,0.9128269,0.0005777416,0.00034609597,0.00072213425,0.0007549762,0.07562902,0.00006484811],"about_ca_topic_score_codex":0.0010222304,"about_ca_topic_score_gemma":0.0015673932,"teacher_disagreement_score":0.0030808833,"about_ca_system_score_codex":0.00058821705,"about_ca_system_score_gemma":0.0008986498,"threshold_uncertainty_score":0.0042678714},"labels":[],"label_agreement":null},{"id":"W2899457817","doi":"10.1007/s13300-018-0524-z","title":"Liraglutide and Glycaemic Outcomes in the LEADER Trial","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute","funders":"Novo Nordisk","keywords":"Liraglutide; Medicine; Diabetes mellitus; Intensive care medicine; Empagliflozin; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.031761159776296614,"score_gpt":0.2979267338069327,"score_spread":0.26616557403063607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899457817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96625715,0.02521134,0.00053880946,0.001829287,0.0002929635,0.00051188114,0.0013042939,0.00015358353,0.0039007186],"genre_scores_gemma":[0.98675156,0.004737315,0.0014333255,0.0012792628,0.0004901472,0.0011517137,0.0015290276,0.000020325106,0.0026073176],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9992366,0.0005420295,0.000034413544,0.00006586371,0.000058293168,0.00006291974],"domain_scores_gemma":[0.99941254,0.00015157442,0.00018502235,0.00005669748,0.000048623973,0.00014557502],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015064455,0.0005199993,0.001476156,0.00014296401,0.00019557752,0.0006927252,0.00030640836,0.00073684944,0.0020651645],"category_scores_gemma":[0.0015766758,0.00016228502,0.0008434895,0.0001922999,0.00030696712,0.00044050105,0.00033171318,0.0013647245,0.0003060665],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8904673,0.0026278566,0.012103419,0.0022995353,0.0035029484,0.00020280559,0.000119987366,0.0010548994,0.003059634,0.0007962484,0.008057054,0.07570841],"study_design_scores_gemma":[0.81941843,0.11429279,0.047082968,0.00062754797,0.004967301,0.00028529135,0.00011214506,0.0027425175,0.0011344167,0.0014091041,0.007861439,0.00006597737],"about_ca_topic_score_codex":0.0006023702,"about_ca_topic_score_gemma":0.0013366529,"teacher_disagreement_score":0.0020651645,"about_ca_system_score_codex":0.00039173057,"about_ca_system_score_gemma":0.000549491,"threshold_uncertainty_score":0.007966936},"labels":[],"label_agreement":null},{"id":"W2904126392","doi":"10.1007/s13300-018-0553-7","title":"Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc Analysis","year":2018,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; Western University; University of Alberta","funders":"Novo Nordisk","keywords":"Insulin aspart; Medicine; Post-hoc analysis; Body mass index; Type 2 diabetes; Internal medicine; Diabetes mellitus; Insulin; Type 1 diabetes; Endocrinology","score_opus":0.015776097888142365,"score_gpt":0.27625360368562524,"score_spread":0.26047750579748286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904126392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936086,0.0019849127,0.0013294504,0.00014522873,0.00031209106,0.0005995861,0.0010813908,0.00003166654,0.00090711017],"genre_scores_gemma":[0.9946467,0.00036666784,0.0014709887,0.0002144179,0.0001644468,0.00091749616,0.0010787564,0.000031481206,0.0011090261],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9870378,0.008632291,0.0009997688,0.00140468,0.0011440684,0.0007814211],"domain_scores_gemma":[0.9775252,0.016252505,0.0021181994,0.001991251,0.0013620382,0.00075092353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015680928,0.0014399381,0.003368786,0.0006948731,0.00042232586,0.0011859444,0.0009451674,0.0010968184,0.003486703],"category_scores_gemma":[0.016349742,0.0005360873,0.010816055,0.000695532,0.00056773116,0.0011967716,0.00081181526,0.002148473,0.0003627666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.68467164,0.0031519772,0.21462943,0.0019716085,0.053414483,0.00043031067,0.00040203283,0.0016795727,0.0060412167,0.00022712973,0.0017345182,0.0316461],"study_design_scores_gemma":[0.038711753,0.1814488,0.7105074,0.00017382635,0.051560063,0.00030213597,0.000497615,0.0055077095,0.007354613,0.000556584,0.0032278926,0.00015153368],"about_ca_topic_score_codex":0.0011952906,"about_ca_topic_score_gemma":0.0017047452,"teacher_disagreement_score":0.015680928,"about_ca_system_score_codex":0.00063625764,"about_ca_system_score_gemma":0.0013324254,"threshold_uncertainty_score":0.08292967},"labels":[],"label_agreement":null},{"id":"W2914739803","doi":"10.1007/s13300-019-0568-8","title":"Rates of Hypoglycemia Predicted in Patients with Type 2 Diabetes on Insulin Glargine 300 U/ml Versus First- and Second-Generation Basal Insulin Analogs: The Real-World LIGHTNING Study","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":65,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lawson Health Research Institute; Western University","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Insulin degludec; Insulin detemir; Hypoglycemia; Insulin; Type 2 diabetes; Diabetes mellitus; Internal medicine; Basal (medicine); Basal insulin; Endocrinology","score_opus":0.021182174102583346,"score_gpt":0.2726222910436291,"score_spread":0.2514401169410458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914739803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869007,0.00011800921,0.0002463307,0.000053499876,0.000008119318,0.000014138158,0.0007078432,0.0000062865383,0.00015571616],"genre_scores_gemma":[0.99767095,0.00006553926,0.0002649196,0.000051422045,0.00002041647,0.000021564663,0.0018414389,0.0000029617627,0.00006061772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979651,0.0011928942,0.00019015577,0.00041521798,0.00015200888,0.0000846424],"domain_scores_gemma":[0.99211097,0.003125071,0.0030727477,0.0009461381,0.00027903038,0.0004660738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003982595,0.00034122216,0.00063532015,0.0007707583,0.0001412685,0.0008809021,0.00060392637,0.0005804658,0.0005847959],"category_scores_gemma":[0.009877541,0.00024643575,0.0014128353,0.0010473226,0.00025042493,0.00077443325,0.0007509488,0.0009830348,0.00012514048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030504968,0.00012553747,0.9915862,0.000020751775,0.00047437253,0.00006179798,0.000059881924,0.0010456335,0.0000909207,0.000063345644,0.00037503632,0.0030458863],"study_design_scores_gemma":[0.0007018448,0.0016520085,0.9772364,0.000025254281,0.00041743074,0.00035986028,0.00038372618,0.0182168,0.00023558727,0.00029515044,0.00043703165,0.00003902659],"about_ca_topic_score_codex":0.0016667394,"about_ca_topic_score_gemma":0.0011947614,"teacher_disagreement_score":0.003982595,"about_ca_system_score_codex":0.00043862933,"about_ca_system_score_gemma":0.00030347757,"threshold_uncertainty_score":0.021062195},"labels":[],"label_agreement":null},{"id":"W2924791861","doi":"10.1007/s13300-019-0594-6","title":"Downregulation of T-Cell Transcription Factors in Adult Latent Autoimmune Diabetes with High-Titer Glutamic Acid Decaroxylase Antibody","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"National Key Research and Development Program of China","keywords":"FOXP3; GATA3; RAR-related orphan receptor gamma; Medicine; Immunology; Peripheral blood mononuclear cell; Titer; Antibody; T cell; Internal medicine; T helper cell; Endocrinology; Diabetes mellitus; Flow cytometry; Transcription factor; Immune system; Biology; Biochemistry; In vitro","score_opus":0.003260832056153989,"score_gpt":0.19534842275032294,"score_spread":0.19208759069416895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924791861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903226,0.0006194506,0.00015284512,0.000011617695,0.000004513177,0.0000031364712,0.000024814004,0.000005763244,0.0001455818],"genre_scores_gemma":[0.9994512,0.00018934008,0.00013919291,0.000022101955,0.000011229154,0.000007415763,0.00005767369,0.0000012459274,0.00012072202],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99990463,0.000024040013,0.000011338632,0.000020962174,0.000016879118,0.000022156562],"domain_scores_gemma":[0.99986863,0.000021154368,0.00005204101,0.000008269661,0.000014849293,0.000034987763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016137076,0.0002038868,0.00019896918,0.00018002113,0.000114599585,0.0001848473,0.00007697342,0.00014960626,0.000976389],"category_scores_gemma":[0.00022603058,0.00007929705,0.00013213216,0.00015791813,0.00017303455,0.000127467,0.00014020417,0.00023779123,0.00017426163],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046842797,0.00029131654,0.19531626,0.00023835024,0.000055550932,0.0015026728,0.00035354245,0.0000699768,0.7815589,0.000066157874,0.00016429792,0.01569885],"study_design_scores_gemma":[0.0002330509,0.0026488497,0.93871397,0.000036960086,0.0001291973,0.005183672,0.0004489362,0.0010034373,0.049714655,0.00011322185,0.0017643194,0.000009755956],"about_ca_topic_score_codex":0.00017164435,"about_ca_topic_score_gemma":0.00017059554,"teacher_disagreement_score":0.000976389,"about_ca_system_score_codex":0.00010828906,"about_ca_system_score_gemma":0.00007946056,"threshold_uncertainty_score":0.0032663345},"labels":[],"label_agreement":null},{"id":"W2942132427","doi":"10.1007/s13300-019-0615-5","title":"GLP-1 RA Treatment and Dosing Patterns Among Type 2 Diabetes Patients in Six Countries: A Retrospective Analysis of Pharmacy Claims Data","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company","keywords":"Medicine; Discontinuation; Exenatide; Type 2 diabetes; Liraglutide; Dulaglutide; Internal medicine; Retrospective cohort study; Dosing; Lira; Pharmacy; Diabetes mellitus; Family medicine; Endocrinology","score_opus":0.01924185101910407,"score_gpt":0.28805187489398093,"score_spread":0.26881002387487685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2942132427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99198884,0.001237168,0.00026328248,0.00006301351,0.0000071999216,0.000037264414,0.006009659,0.000010401926,0.00038317675],"genre_scores_gemma":[0.9948602,0.0004545246,0.00029693698,0.000054689834,0.000005711842,0.000034318087,0.004245813,0.0000056988597,0.000042245472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99493235,0.0013430599,0.0013755142,0.0011948252,0.0008085036,0.00034580717],"domain_scores_gemma":[0.98770523,0.0020807362,0.007715758,0.0011585752,0.00089345186,0.0004463207],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003408063,0.00034600397,0.0006695936,0.002914662,0.00044217822,0.0016304757,0.00054180395,0.0004526702,0.00084564823],"category_scores_gemma":[0.007866235,0.0005633195,0.0011884832,0.00750954,0.00046245588,0.0007609668,0.0011446287,0.0005543148,0.00024751353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091351976,0.000010973758,0.9984793,0.00003499971,0.00014794977,0.000056899327,0.00006529752,0.00007399941,0.0000437723,0.000014762356,0.00014559213,0.0008350585],"study_design_scores_gemma":[0.000021435553,0.00008039049,0.99688077,0.00006863146,0.00017699738,0.0007857264,0.00054081425,0.0004581284,0.000115747964,0.000019126255,0.00083924306,0.000013010772],"about_ca_topic_score_codex":0.011388171,"about_ca_topic_score_gemma":0.008795136,"teacher_disagreement_score":0.011388171,"about_ca_system_score_codex":0.00085493975,"about_ca_system_score_gemma":0.0010468289,"threshold_uncertainty_score":0.022643805},"labels":[],"label_agreement":null},{"id":"W2973028609","doi":"10.1007/s13300-019-00687-y","title":"Family Members: The Forgotten Players in the Diabetes Care Team (The TALK-HYPO Study)","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Novo Nordisk","keywords":"Hypoglycemia; Medicine; Diabetes mellitus; Type 1 diabetes; Family medicine; Type 2 diabetes; Health care; Pediatrics; Nursing; Endocrinology","score_opus":0.014958111875017766,"score_gpt":0.2623535770906601,"score_spread":0.24739546521564232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2973028609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963541,0.00061709253,0.00011383635,0.00068599393,0.00006938135,0.00010172714,0.00033061943,0.0000041861063,0.0017230498],"genre_scores_gemma":[0.99708384,0.00047303646,0.00013824218,0.0008017154,0.00004566784,0.00026270057,0.00020375801,0.000005135374,0.0009859342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984352,0.0007969166,0.00009992676,0.00019843587,0.00022058345,0.00024888202],"domain_scores_gemma":[0.9977463,0.00043917348,0.00067516125,0.000110841385,0.00018368484,0.0008449055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022179468,0.00037811793,0.00044949536,0.0006862633,0.0031993901,0.001918015,0.00057285937,0.0008479701,0.003425957],"category_scores_gemma":[0.005145478,0.00052574044,0.0005744644,0.0006593142,0.00075865665,0.0019246176,0.002525953,0.0016396709,0.0004683312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016509943,0.0016311669,0.90798646,0.00039538252,0.00023248969,0.0015936332,0.054522708,0.000043202435,0.00058309553,0.00047441735,0.005673789,0.025212644],"study_design_scores_gemma":[0.0003937553,0.0020850264,0.8204524,0.0008499073,0.00024177574,0.0023744288,0.16321,0.00014293515,0.0002548352,0.00073372317,0.009162225,0.00009904256],"about_ca_topic_score_codex":0.016149925,"about_ca_topic_score_gemma":0.015103203,"teacher_disagreement_score":0.016149925,"about_ca_system_score_codex":0.0010777664,"about_ca_system_score_gemma":0.0017372676,"threshold_uncertainty_score":0.032111883},"labels":[],"label_agreement":null},{"id":"W2982342400","doi":"10.1007/s13300-019-00715-x","title":"Glomerular Filtration Rate and Associated Risks ofCardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes:Secondary Analysis (DEVOTE 11)","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lunenfeld-Tanenbaum Research Institute; University of Toronto","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Janssen Research and Development; National Institutes of Health; Novo Nordisk; European Association for the Study of Diabetes; Zafgen; Eli Lilly and Company; AstraZeneca; CSL Behring; Merck Sharp and Dohme; Eisai; Sanofi; MannKind Corporation; GlaxoSmithKline; Pfizer","keywords":"Medicine; Hypoglycemia; Diabetes mellitus; Renal function; Type 2 diabetes; Type 1 diabetes; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.011898879180850336,"score_gpt":0.2452931604264202,"score_spread":0.23339428124556985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982342400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98118913,0.0065132077,0.0013409524,0.00012482694,0.00012761772,0.0005180465,0.009076886,0.00004952551,0.0010597118],"genre_scores_gemma":[0.9899552,0.00088715425,0.00079996896,0.00014332344,0.00017089871,0.00072046934,0.0065040863,0.000019610225,0.00079930853],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9963399,0.0022222993,0.00031356796,0.0005665693,0.00035785153,0.0001997738],"domain_scores_gemma":[0.9957124,0.0020525728,0.0010300629,0.0005205077,0.00036445717,0.00032007974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062305825,0.001435077,0.0040808017,0.0010151371,0.00028368775,0.0014864114,0.0007121097,0.0007712047,0.0027742763],"category_scores_gemma":[0.004666772,0.0006100714,0.010472693,0.0011587997,0.00040199116,0.00054739974,0.00091749965,0.0013763235,0.00021314101],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.56431866,0.0015831363,0.27482373,0.0050127623,0.13117772,0.0002754885,0.00012511527,0.0033465377,0.0027366092,0.00032556526,0.0032497325,0.013024828],"study_design_scores_gemma":[0.17860533,0.038699977,0.6560157,0.00047689362,0.10789096,0.00095193344,0.00018500283,0.008138414,0.0024945342,0.0011731823,0.0051453356,0.00022267112],"about_ca_topic_score_codex":0.0012689625,"about_ca_topic_score_gemma":0.0016749902,"teacher_disagreement_score":0.0062305825,"about_ca_system_score_codex":0.00041670457,"about_ca_system_score_gemma":0.00074077136,"threshold_uncertainty_score":0.03295082},"labels":[],"label_agreement":null},{"id":"W2982524000","doi":"10.1007/s13300-019-00716-w","title":"The Association Between Phosphorylated Neurofilament Heavy Chain (pNF-H) and Small Fiber Neuropathy (SFN) in Patients with Impaired Glucose Tolerance","year":2019,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Tianjin Medical University; Natural Science Foundation of Tianjin City","keywords":"Medicine; Impaired glucose tolerance; Diabetes mellitus; Diabetic neuropathy; Internal medicine; Phosphorylation; Neurofilament; Endocrinology; Type 2 diabetes; Biochemistry; Immunohistochemistry; Biology","score_opus":0.005446343467524524,"score_gpt":0.1910564402811468,"score_spread":0.18561009681362228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2982524000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994917,0.0002597859,0.0000436342,0.000012883075,0.000004126555,0.0000024429705,0.000046853802,0.0000020348791,0.00013651361],"genre_scores_gemma":[0.9997615,0.00006483632,0.00005017689,0.0000089683635,0.0000072794173,0.000002006846,0.00006390142,4.3421457e-7,0.00004090549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998271,0.000034991852,0.000027735821,0.000042806558,0.00003700517,0.000030450394],"domain_scores_gemma":[0.9991586,0.00018475778,0.00037580935,0.000031558935,0.00007986005,0.00016947862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033233548,0.00037716894,0.00027594314,0.0008122056,0.0003285119,0.0003195053,0.00023992146,0.0004394251,0.0016484783],"category_scores_gemma":[0.001262179,0.00017321086,0.00021441148,0.0007615526,0.00024299503,0.00027785817,0.00022044887,0.0003265883,0.00015014061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023747719,0.000026982041,0.99808973,0.000009935219,0.000025464113,0.00020120434,0.000019020988,0.000020707628,0.00034484992,0.000003966748,0.00002658235,0.0009941229],"study_design_scores_gemma":[0.000007267463,0.0001425502,0.99848723,0.0000038787093,0.000020866348,0.0010480253,0.000044248598,0.00012708685,0.00006502733,0.000012955283,0.0000387718,0.0000019260458],"about_ca_topic_score_codex":0.0014549162,"about_ca_topic_score_gemma":0.0012781937,"teacher_disagreement_score":0.0016484783,"about_ca_system_score_codex":0.00017572983,"about_ca_system_score_gemma":0.00012767308,"threshold_uncertainty_score":0.005514741},"labels":[],"label_agreement":null},{"id":"W3000373527","doi":"10.1007/s13300-019-00749-1","title":"Impact of Switching from Twice-Daily Basal Insulin to Once-Daily Insulin Glargine 300 U/mL in People with Type 1 Diabetes on Basal–Bolus Insulin: Phase 4 OPTIMIZE Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Universitaire Ziekenhuizen Leuven, KU Leuven; Sanofi","keywords":"Insulin glargine; Medicine; Basal insulin; Insulin; Basal (medicine); Diabetes mellitus; Internal medicine; Endocrinology; Type 2 diabetes","score_opus":0.03087325850078365,"score_gpt":0.32439062941125585,"score_spread":0.2935173709104722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3000373527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968244,0.0010860463,0.00016546907,0.00018591789,0.00008320847,0.00062561524,0.00028042498,0.00004327193,0.0007056806],"genre_scores_gemma":[0.99457234,0.0008908696,0.0012368606,0.0007462849,0.00017744121,0.0012080359,0.0005010814,0.000015711254,0.00065132364],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9991248,0.00047299548,0.00006418616,0.00014385748,0.000074423595,0.000119680415],"domain_scores_gemma":[0.99892056,0.00039973488,0.00022081027,0.00008186406,0.00007046551,0.00030661616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017185892,0.000926399,0.0023159953,0.0003010262,0.00031949556,0.0009037352,0.0006687632,0.0011833485,0.0043904227],"category_scores_gemma":[0.0023724446,0.00041133154,0.002679311,0.00028984953,0.0003860051,0.0007264138,0.00044119128,0.0021474722,0.00043296753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8531387,0.04469797,0.004676015,0.0008498368,0.0020455993,0.000078075886,0.00014214168,0.0008737342,0.0028837272,0.000064973145,0.00083585933,0.08971335],"study_design_scores_gemma":[0.63004065,0.34101012,0.023666836,0.000116389776,0.0015543484,0.000088451416,0.00009764347,0.0016352289,0.0007460314,0.00015389055,0.0008430202,0.00004739898],"about_ca_topic_score_codex":0.00120054,"about_ca_topic_score_gemma":0.001396969,"teacher_disagreement_score":0.0043904227,"about_ca_system_score_codex":0.00061892776,"about_ca_system_score_gemma":0.00078067614,"threshold_uncertainty_score":0.014687419},"labels":[],"label_agreement":null},{"id":"W3008199068","doi":"10.1007/s13300-020-00775-4","title":"Development and Validation of a New Diabetes Risk Score in Guyana","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"Medical Research Council; Banting and Best Diabetes Centre, University of Toronto; World Diabetes Foundation; University of Toronto","keywords":"Medicine; Diabetes mellitus; Framingham Risk Score; Cohort; Population; Demography; Pandemic; Environmental health; Gerontology; Disease; Internal medicine; Coronavirus disease 2019 (COVID-19); Endocrinology","score_opus":0.031073245118525494,"score_gpt":0.2411962630718062,"score_spread":0.2101230179532807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3008199068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98184764,0.00071052555,0.009626549,0.0009645162,0.00011672188,0.00070520164,0.0018467281,0.00014888859,0.0040332517],"genre_scores_gemma":[0.9774064,0.0002543156,0.019310564,0.00018019183,0.000023495943,0.0005033351,0.0016311805,0.000019593626,0.0006708629],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975937,0.00125725,0.000256799,0.00023011651,0.0004907125,0.00017150653],"domain_scores_gemma":[0.99683183,0.0009838891,0.00064566266,0.00027991037,0.0010735157,0.00018526582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003715365,0.0007022972,0.0004460674,0.001784382,0.00043392178,0.0012692092,0.00070640125,0.00048795875,0.0013976757],"category_scores_gemma":[0.0071932464,0.00026062812,0.00077315717,0.0011300428,0.00048705726,0.00046983,0.0012377287,0.00089242886,0.00058540574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079261645,0.00034946037,0.9248135,0.00020532073,0.00024304133,0.00032394956,0.0009434076,0.002143686,0.0017933747,0.00049326103,0.0016321855,0.06626617],"study_design_scores_gemma":[0.00039496078,0.0018720799,0.9704785,0.0004500329,0.00029230572,0.00093740446,0.0012502547,0.014315389,0.0023872263,0.00066043204,0.006869224,0.00009227046],"about_ca_topic_score_codex":0.009844765,"about_ca_topic_score_gemma":0.009758357,"teacher_disagreement_score":0.009844765,"about_ca_system_score_codex":0.0011019743,"about_ca_system_score_gemma":0.0012529392,"threshold_uncertainty_score":0.01964897},"labels":[],"label_agreement":null},{"id":"W3010968620","doi":"10.1007/s13300-020-00797-y","title":"Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Beekeepers' Association","funders":"Sanofi","keywords":"Lixisenatide; Medicine; Insulin glargine; Type 2 diabetes; Internal medicine; Glycated hemoglobin; Endocrinology; Diabetes mellitus; Insulin; Quartile; Gastroenterology; Gastric emptying; Exenatide; Insulin degludec; Confidence interval","score_opus":0.01154119011127701,"score_gpt":0.22026403721401855,"score_spread":0.20872284710274153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010968620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823528,0.015211079,0.0006205368,0.00023177796,0.00012825301,0.00021972986,0.00058937445,0.000030356876,0.00061611243],"genre_scores_gemma":[0.9968669,0.0013896936,0.0003151438,0.00027158807,0.00009214666,0.00016312068,0.0006154372,0.000010729219,0.00027520146],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99679935,0.0019646427,0.00028861224,0.0004972663,0.00020648268,0.00024360581],"domain_scores_gemma":[0.99683315,0.0012560219,0.0009351292,0.00042676568,0.00017497032,0.00037411676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004953861,0.0012363325,0.0035853295,0.00036789017,0.00025902808,0.0011752441,0.000807059,0.00080689206,0.0024771271],"category_scores_gemma":[0.003812148,0.00059974927,0.008158343,0.0006770177,0.0005182449,0.0010104997,0.000654385,0.0017804623,0.0003067524],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.85837024,0.00081959966,0.0672736,0.0012437733,0.056016777,0.000107129395,0.00006821818,0.0008208614,0.0012418821,0.000098313176,0.0007242578,0.013215299],"study_design_scores_gemma":[0.3852065,0.1445674,0.3549973,0.00038763482,0.10381186,0.0005184935,0.00038615777,0.004977201,0.0011568173,0.0007458027,0.0030920461,0.00015270425],"about_ca_topic_score_codex":0.0012107689,"about_ca_topic_score_gemma":0.0018284763,"teacher_disagreement_score":0.004953861,"about_ca_system_score_codex":0.0008291222,"about_ca_system_score_gemma":0.0005989282,"threshold_uncertainty_score":0.026198864},"labels":[],"label_agreement":null},{"id":"W3015457795","doi":"10.1007/s13300-020-00802-4","title":"Systemic Delivery of siRNA Specific for Silencing TLR4 Gene Expression Reduces Diabetic Cardiomyopathy in a Mouse Model of Streptozotocin-Induced Type 1 Diabetes","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Cardiac Fibrosis and Remodeling","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"National Natural Science Foundation of China","keywords":"Diabetic cardiomyopathy; Streptozotocin; Gene silencing; Medicine; Diabetes mellitus; TLR4; Type 2 diabetes; Gene; Cardiomyopathy; Gene expression; Bioinformatics; Internal medicine; Endocrinology; Genetics; Heart failure; Biology; Receptor","score_opus":0.04397344159512325,"score_gpt":0.25412198887767756,"score_spread":0.2101485472825543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015457795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857838,0.0033326154,0.006526173,0.00034119943,0.00020862035,0.00015204892,0.0010625421,0.00041034186,0.0021827049],"genre_scores_gemma":[0.9784228,0.0035911372,0.0087621845,0.00027593874,0.000056673216,0.00051420333,0.0016860383,0.00008152853,0.0066094757],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9997756,0.000026465577,0.000024647912,0.00005672603,0.00005325874,0.0000632567],"domain_scores_gemma":[0.9998165,0.000017859851,0.000073417614,0.000012692632,0.000024334468,0.000055229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003150327,0.0006246914,0.0007021115,0.00048887334,0.00018231566,0.00032374158,0.0003278383,0.0005826731,0.0015904988],"category_scores_gemma":[0.00010863576,0.00021749256,0.0003918779,0.00026430815,0.00030893332,0.00024598226,0.00016217255,0.0010432608,0.00036367032],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048177247,0.0001629792,0.00012388025,0.00010514753,0.0000133859585,0.000028872364,0.000014714966,0.00006012458,0.9975841,0.000057613946,0.00009489355,0.0012725346],"study_design_scores_gemma":[0.0002513593,0.002928827,0.0043988586,0.00003380034,0.00011157992,0.00015640348,0.000062415595,0.0015998755,0.9880769,0.00005735508,0.0023096437,0.000012950269],"about_ca_topic_score_codex":0.0005245418,"about_ca_topic_score_gemma":0.00090123503,"teacher_disagreement_score":0.0015904988,"about_ca_system_score_codex":0.0003112787,"about_ca_system_score_gemma":0.00033177578,"threshold_uncertainty_score":0.005320728},"labels":[],"label_agreement":null},{"id":"W3016314642","doi":"10.1007/s13300-020-00818-w","title":"Recreational Cannabis Usage Among Young Adults Living with Diabetes: Protocol for a Mixed Methods Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Impact; Population Health Research Institute; Hamilton Health Sciences; University of Toronto; Toronto Metropolitan University; SickKids Foundation; Hospital for Sick Children; McMaster University; Women's College Hospital","funders":"","keywords":"Medicine; Diabetes mellitus; Cannabis; Recreation; Gerontology; Protocol (science); Recreational Drug; Psychiatry; Environmental health; Alternative medicine; Endocrinology; Ecology; Pathology","score_opus":0.03044083539171841,"score_gpt":0.36507724351955895,"score_spread":0.3346364081278405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3016314642","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006207575,0.000059612637,0.0008496944,0.000074619056,0.00007486561,0.9973515,0.0006365741,0.000019984176,0.0003124349],"genre_scores_gemma":[0.0002811052,0.00004165556,0.0012768506,0.000054356402,0.00000787445,0.9981812,0.00006293678,0.0000015379968,0.00009242201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.977398,0.01268331,0.004329967,0.0015454505,0.0021265892,0.0019167241],"domain_scores_gemma":[0.9728721,0.008304666,0.0032755411,0.0037187852,0.009542073,0.0022869047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.057748836,0.00407815,0.006198113,0.004153689,0.006169562,0.0041573965,0.0038960865,0.005810468,0.08179788],"category_scores_gemma":[0.0394453,0.0043078572,0.0056850906,0.0042866752,0.0024120167,0.0039342768,0.0029582288,0.0070827403,0.014720042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1268872,0.07096565,0.0137550505,0.16372094,0.0024455837,0.00504437,0.03391046,0.011450224,0.010615946,0.026425423,0.21128236,0.32349694],"study_design_scores_gemma":[0.2078071,0.050423644,0.053467933,0.062952235,0.0016831628,0.0009945384,0.026101109,0.008157486,0.006550056,0.022926165,0.5577521,0.0011845195],"about_ca_topic_score_codex":0.0072417054,"about_ca_topic_score_gemma":0.015321253,"teacher_disagreement_score":0.08179788,"about_ca_system_score_codex":0.00652661,"about_ca_system_score_gemma":0.025862006,"threshold_uncertainty_score":0.30540872},"labels":[],"label_agreement":null},{"id":"W3019736633","doi":"10.1007/s13300-020-00812-2","title":"Latest Evidence on Sulfonylureas: What’s New?","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Servier","keywords":"Medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Clinical trial; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.11721029630246166,"score_gpt":0.35704289838259157,"score_spread":0.2398326020801299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3019736633","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042086904,0.9989681,0.000028629427,0.0005042685,0.00024189611,0.000002774368,0.000014795763,0.000002055818,0.00019537199],"genre_scores_gemma":[0.00032011283,0.99899715,0.0000606024,0.00037419162,0.00017301679,0.0000036600975,0.000015693893,6.7948855e-7,0.000054795986],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993036,0.00016398243,0.0001843843,0.00009749915,0.00020387187,0.0000466802],"domain_scores_gemma":[0.9970192,0.0021154017,0.00033339643,0.000049126287,0.00040537736,0.00007752953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019325828,0.00095035875,0.0029274109,0.002679339,0.0002956418,0.002003463,0.0010548579,0.0015131774,0.0048544584],"category_scores_gemma":[0.0047813472,0.0004108421,0.001686245,0.0036338074,0.000521039,0.002188464,0.00079386984,0.0022228474,0.0009419211],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020448574,0.000038364837,0.00020894886,0.12404474,0.00078054436,0.00011942048,0.000103017606,0.00015701464,0.00041832458,0.0026121596,0.023555791,0.84775716],"study_design_scores_gemma":[0.00011243793,0.00021880696,0.001570403,0.12058465,0.0027437203,0.000649454,0.00021294442,0.00009415843,0.00024854852,0.0031120875,0.87041146,0.00004124401],"about_ca_topic_score_codex":0.0021168343,"about_ca_topic_score_gemma":0.0043482264,"teacher_disagreement_score":0.0048544584,"about_ca_system_score_codex":0.00074809144,"about_ca_system_score_gemma":0.0025460336,"threshold_uncertainty_score":0.016239822},"labels":[],"label_agreement":null},{"id":"W3034312489","doi":"10.1007/s13300-020-00851-9","title":"The Effectiveness of Acceptance and Commitment Therapy on Pain Acceptance and Pain Perception in Patients with Painful Diabetic Neuropathy: A Randomized Controlled Trial","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Deputy for Research and Technology, Kermanshah University of Medical Sciences; Kermanshah University of Medical Sciences; Bausch Health; Ortho Dermatologics","keywords":"Acceptance and commitment therapy; Medicine; Physical therapy; Neuropathic pain; Randomized controlled trial; Intervention (counseling); McGill Pain Questionnaire; Clinical trial; Chronic pain; Diabetic neuropathy; Test (biology); Diabetes mellitus; Psychiatry; Surgery; Anesthesia; Internal medicine; Visual analogue scale","score_opus":0.008025394181544177,"score_gpt":0.22792429264848021,"score_spread":0.21989889846693603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3034312489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9305775,0.018720549,0.0011085628,0.0011443562,0.0013826061,0.04408812,0.0009205984,0.00014089287,0.0019168565],"genre_scores_gemma":[0.8855864,0.011458032,0.0050775805,0.001576769,0.0014965811,0.09047589,0.00081808446,0.000022629996,0.0034880512],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99704355,0.0016141408,0.00038220797,0.00038393083,0.00031079096,0.00026527213],"domain_scores_gemma":[0.99659306,0.0011804843,0.0008249888,0.00025229517,0.0003403366,0.00080885115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043593263,0.0015813351,0.006673892,0.00089151313,0.0011932458,0.001355625,0.001538098,0.003403329,0.009132573],"category_scores_gemma":[0.0049813716,0.00090297824,0.0041308105,0.0011552155,0.0017204997,0.0013810187,0.00076200225,0.0032958211,0.0006416506],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9697908,0.015560653,0.0005961175,0.0030445282,0.0014924422,0.000031881056,0.00006665433,0.000087237095,0.00042923063,0.00008310436,0.00022870979,0.008588678],"study_design_scores_gemma":[0.9405213,0.056302335,0.0012909055,0.0001909015,0.0010860692,0.0000127317135,0.000031107393,0.0001605012,0.00011559586,0.000061176135,0.00021526443,0.000012083298],"about_ca_topic_score_codex":0.0012609258,"about_ca_topic_score_gemma":0.0019024144,"teacher_disagreement_score":0.009132573,"about_ca_system_score_codex":0.0010611953,"about_ca_system_score_gemma":0.003122964,"threshold_uncertainty_score":0.030551493},"labels":[],"label_agreement":null},{"id":"W3038415136","doi":"10.1007/s13300-020-00869-z","title":"Evaluation of Characteristics of Gastrointestinal Adverse Events with Once-Weekly Dulaglutide Treatment in Chinese Patients with Type 2 Diabetes: A Post Hoc Pooled Analysis of Two Randomized Trials","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Education and Child Care","funders":"Eli Lilly and Company","keywords":"Medicine; Dulaglutide; Post-hoc analysis; Type 2 diabetes; Diabetes mellitus; Adverse effect; Internal medicine; Randomized controlled trial; Pooled analysis; Post hoc; Traditional medicine; Exenatide; Meta-analysis; Endocrinology","score_opus":0.02863615751985996,"score_gpt":0.30221426936298373,"score_spread":0.27357811184312375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038415136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9280492,0.056401625,0.005686185,0.00032666844,0.00061453914,0.0042104805,0.0033692233,0.0001678023,0.0011742894],"genre_scores_gemma":[0.98853624,0.003299178,0.0026439943,0.00027291934,0.00022355065,0.0030022745,0.0016124309,0.000025101957,0.00038428034],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98031276,0.011883114,0.0032476592,0.0024051378,0.0016552536,0.0004961574],"domain_scores_gemma":[0.9712288,0.017457202,0.007143557,0.0020511153,0.0015601846,0.0005591261],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.031258456,0.0019038456,0.009476417,0.002049092,0.00044187505,0.0015313793,0.0010583714,0.001333833,0.002042131],"category_scores_gemma":[0.02224217,0.00061478274,0.01902189,0.0021718256,0.00074379885,0.0010324386,0.0007606445,0.0010365745,0.00012609838],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.358074,0.0006178204,0.078866765,0.010464086,0.52819926,0.00022854464,0.0001642779,0.002169127,0.0020065166,0.00010702874,0.0007222519,0.018380376],"study_design_scores_gemma":[0.09995839,0.04238515,0.24694504,0.00052637706,0.59804493,0.0002933013,0.00023906524,0.0073679495,0.0018568576,0.0004377712,0.0017436243,0.00020154804],"about_ca_topic_score_codex":0.0009819687,"about_ca_topic_score_gemma":0.001429885,"teacher_disagreement_score":0.031258456,"about_ca_system_score_codex":0.0010436802,"about_ca_system_score_gemma":0.0014789059,"threshold_uncertainty_score":0.16531247},"labels":[],"label_agreement":null},{"id":"W3044377510","doi":"10.1007/s13300-020-00884-0","title":"Burden of Diabetes and Prediabetes in Nepal: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prediabetes; Medicine; Diabetes mellitus; Meta-analysis; Intensive care medicine; Systematic review; MEDLINE; Traditional medicine; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.05304638649614409,"score_gpt":0.3116499172448164,"score_spread":0.2586035307486723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3044377510","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004158229,0.9934968,0.0004765585,0.00022947985,0.00008996609,0.00037469683,0.00089055696,0.000022714083,0.00026107833],"genre_scores_gemma":[0.11055902,0.88329345,0.0021860665,0.0006784711,0.00015876415,0.0016582074,0.0011771489,0.000023680697,0.0002652351],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99184555,0.0031423909,0.002780458,0.0008687527,0.0009958361,0.0003670747],"domain_scores_gemma":[0.9812602,0.013796398,0.0026600314,0.0005202288,0.001563318,0.00019979938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0134497695,0.002561157,0.016765095,0.009141454,0.00077080494,0.003622761,0.0023828708,0.0020388968,0.0037256004],"category_scores_gemma":[0.0336177,0.0016802138,0.03407102,0.00993541,0.00063947175,0.002155137,0.0021714682,0.0018596664,0.00024592574],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007430494,0.000027514177,0.006038334,0.63221246,0.34440914,0.00019773704,0.00016428174,0.0005299632,0.00012857046,0.00016973568,0.00080964126,0.014569549],"study_design_scores_gemma":[0.00028113314,0.0001390101,0.0066125356,0.0811972,0.9083883,0.00018604354,0.000107038664,0.00025192968,0.00010285918,0.00020999566,0.0024891663,0.00003477679],"about_ca_topic_score_codex":0.008291253,"about_ca_topic_score_gemma":0.017780973,"teacher_disagreement_score":0.016765095,"about_ca_system_score_codex":0.0030361952,"about_ca_system_score_gemma":0.0057302387,"threshold_uncertainty_score":0.07113004},"labels":[],"label_agreement":null},{"id":"W3083494942","doi":"10.1007/s13300-020-00913-y","title":"Insulin Injection Practices in a Population of Canadians with Diabetes: An Observational Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Communications Research Centre Canada; Manitoba Beekeepers' Association; Cégep Saint-Jean-sur-Richelieu","funders":"BD; Dexcom; Novo Nordisk; Sanofi; Janssen Pharmaceuticals; AstraZeneca; Eli Lilly and Company; Amgen","keywords":"Medicine; Insulin; Diabetes mellitus; Insulin pen; Observational study; Population; Injection site; Clinical Practice; Type 2 diabetes; Internal medicine; Surgery; Endocrinology; Physical therapy","score_opus":0.16018355727305933,"score_gpt":0.369118346198004,"score_spread":0.20893478892494466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083494942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976655,0.00019749836,0.000040640312,0.00017545962,0.0000052206715,0.000049958126,0.0009425117,0.0000037368857,0.00091948954],"genre_scores_gemma":[0.99861443,0.00028503922,0.00014180993,0.0001605324,0.000005872781,0.000022536238,0.0006112329,0.0000019251563,0.00015660324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985973,0.00009984571,0.00009548474,0.00018653316,0.000665654,0.00035513175],"domain_scores_gemma":[0.99675214,0.00022273304,0.0011074167,0.00008419034,0.001025084,0.0008085145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097181037,0.00031714636,0.0004188186,0.0011577471,0.0026223573,0.0012090644,0.0011398873,0.00063131563,0.0016222262],"category_scores_gemma":[0.0032258509,0.00042362884,0.0005457699,0.004165886,0.0007500445,0.00054324255,0.0007546134,0.00093089195,0.00019689213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038451184,0.000079464175,0.9969344,0.000027006923,0.000024274204,0.000050606843,0.00090884103,0.0000197404,0.000061692306,0.000016347598,0.0003454777,0.0014937123],"study_design_scores_gemma":[0.000007636414,0.00005674898,0.9975434,0.000021616057,0.000013471598,0.00006286622,0.0018844081,0.00011159984,0.000015306752,0.0000051483353,0.00027094784,0.000006926085],"about_ca_topic_score_codex":0.9660587,"about_ca_topic_score_gemma":0.96329886,"teacher_disagreement_score":0.03394133,"about_ca_system_score_codex":0.013894569,"about_ca_system_score_gemma":0.016868645,"threshold_uncertainty_score":0.10081267},"labels":[],"label_agreement":null},{"id":"W3083620810","doi":"10.1007/s13300-020-00916-9","title":"A Prospective Longitudinal Study on the Relationship Between Glucose Fluctuation and Cognitive Function in Type 2 Diabetes: PROPOSAL Study Protocol","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Japan Society for the Promotion of Science; National Cerebral and Cardiovascular Center; Japan Agency for Medical Research and Development","keywords":"Medicine; Glycated hemoglobin; Type 2 Diabetes Mellitus; Dementia; Internal medicine; Type 2 diabetes; Montreal Cognitive Assessment; Diabetes mellitus; Cognition; Glycemic; Prospective cohort study; Cardiology; Disease; Endocrinology; Insulin; Psychiatry","score_opus":0.08434608687979206,"score_gpt":0.37258313243528035,"score_spread":0.2882370455554883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083620810","genre_codex":"protocol","genre_gemma":"protocol","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"protocol","genre_consensus":"protocol","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012541436,0.00039102032,0.0031452493,0.00031083112,0.0002440337,0.97347575,0.008257192,0.000084950894,0.0015495891],"genre_scores_gemma":[0.0074815117,0.00024605697,0.0040683565,0.0003278687,0.00008694967,0.9830934,0.004075302,0.00000790029,0.00061268697],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9865849,0.008291342,0.0017132349,0.00143126,0.0008460314,0.0011331163],"domain_scores_gemma":[0.9899878,0.0014996944,0.001540615,0.0013350897,0.0034661589,0.0021706964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026593838,0.0049618375,0.00405522,0.0016015559,0.0038207793,0.001705845,0.003626689,0.0045351884,0.025563128],"category_scores_gemma":[0.013096429,0.0027178028,0.002580947,0.002679046,0.0017325405,0.0020037137,0.0022257862,0.003793742,0.011685424],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.58434564,0.051922917,0.14506595,0.020234965,0.003253772,0.0015078462,0.001918781,0.0054159346,0.008292163,0.0053987443,0.074891515,0.09775171],"study_design_scores_gemma":[0.48256424,0.10835527,0.27428627,0.006160928,0.0028210469,0.0007949278,0.0012842925,0.0047973846,0.0023749832,0.0043703252,0.111622676,0.00056770624],"about_ca_topic_score_codex":0.0031441762,"about_ca_topic_score_gemma":0.0050988435,"teacher_disagreement_score":0.026593838,"about_ca_system_score_codex":0.0026426204,"about_ca_system_score_gemma":0.016660977,"threshold_uncertainty_score":0.1406433},"labels":[],"label_agreement":null},{"id":"W3087074883","doi":"10.1007/s13300-020-00915-w","title":"Understanding the Clinical Profile of Insulin Degludec, the Latest Basal Insulin Approved for Use in Canada: a Narrative Review","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; University of Manitoba","funders":"Novo Nordisk","keywords":"Insulin degludec; Medicine; Insulin glargine; Insulin; Basal insulin; Pharmacodynamics; Dosing; Hypoglycemia; Basal (medicine); Pharmacology; Intensive care medicine; Pharmacokinetics; Diabetes mellitus; Endocrinology; Type 2 diabetes","score_opus":0.3210177804826985,"score_gpt":0.41142747186803763,"score_spread":0.09040969138533911,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3087074883","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00005847555,0.999119,0.000029461542,0.00024290224,0.00005519837,0.000004621919,0.000032516542,0.000002026335,0.00045578845],"genre_scores_gemma":[0.0005382441,0.9989968,0.00007517213,0.00018099343,0.000039885294,0.0000044897797,0.000034674504,6.487966e-7,0.00012906923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996105,0.000053294858,0.00008822455,0.00005690694,0.00016275582,0.000028419207],"domain_scores_gemma":[0.9984118,0.0007600555,0.00025873448,0.000020154152,0.00048425028,0.000064907625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010094191,0.00066948927,0.00138248,0.0035060148,0.0003820174,0.0014825854,0.00089236733,0.00084919826,0.0038791865],"category_scores_gemma":[0.0025019206,0.00027751084,0.0009222913,0.0043453868,0.00048454804,0.0011365749,0.000517447,0.0012515617,0.00076015975],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014454138,0.000038388076,0.00038276744,0.124365665,0.00032559643,0.00021373732,0.00015081213,0.00024459203,0.0006844009,0.002710892,0.03246073,0.83827776],"study_design_scores_gemma":[0.000037291644,0.00012162703,0.002462775,0.07106293,0.0013742787,0.0014740372,0.00021067921,0.00012759026,0.0003666358,0.0010802654,0.92163676,0.00004503983],"about_ca_topic_score_codex":0.02659222,"about_ca_topic_score_gemma":0.05101463,"teacher_disagreement_score":0.9734078,"about_ca_system_score_codex":0.00222836,"about_ca_system_score_gemma":0.0068750205,"threshold_uncertainty_score":0.052874863},"labels":[],"label_agreement":null},{"id":"W3088605312","doi":"10.1007/s13300-020-00925-8","title":"The Safety and Efficacy of Second-Generation Basal Insulin Analogues in Adults with Type 2 Diabetes at Risk of Hypoglycemia and Use in Other Special Populations: A Narrative Review","year":2020,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Sanofi","keywords":"Medicine; Hypoglycemia; Insulin glargine; Insulin; Diabetes mellitus; Glycated hemoglobin; Type 2 diabetes; Glycemic; Internal medicine; Insulin degludec; Type 2 Diabetes Mellitus; Population; Type 1 diabetes; Endocrinology; Intensive care medicine","score_opus":0.048802162982596015,"score_gpt":0.3233986099411573,"score_spread":0.27459644695856134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3088605312","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00029401708,0.99921596,0.00003997566,0.00011880451,0.000045210705,0.000017054768,0.000046467318,0.0000016795844,0.00022084881],"genre_scores_gemma":[0.0030896696,0.9963595,0.000121177785,0.00023451644,0.00007288095,0.000025037449,0.00004734347,9.270604e-7,0.000048955815],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989221,0.0002726184,0.00042973278,0.000107487205,0.00023429119,0.000033857432],"domain_scores_gemma":[0.9953446,0.0033911862,0.0009101413,0.000042853917,0.0002733455,0.00003776417],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018655892,0.00064063375,0.002610695,0.0020149385,0.00021389998,0.0015628345,0.0007909065,0.0010911183,0.0026362424],"category_scores_gemma":[0.006724078,0.0002781105,0.0033572821,0.0021708193,0.000311937,0.00094867335,0.0004858776,0.0008947891,0.00025505747],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006436432,0.00006922932,0.00089319726,0.59935737,0.00372832,0.00028592904,0.00017617064,0.00028573046,0.00049783447,0.0009739599,0.0068382425,0.3862504],"study_design_scores_gemma":[0.0006223281,0.0011382186,0.009650731,0.61321276,0.04853858,0.0043868446,0.00046402944,0.000460538,0.0009412459,0.0022795189,0.31819087,0.00011438613],"about_ca_topic_score_codex":0.0012774311,"about_ca_topic_score_gemma":0.0020694153,"teacher_disagreement_score":0.0026362424,"about_ca_system_score_codex":0.00051154016,"about_ca_system_score_gemma":0.0017335205,"threshold_uncertainty_score":0.009866357},"labels":[],"label_agreement":null},{"id":"W3093021192","doi":"10.1007/s13300-020-00939-2","title":"A Coloured Pen Needle Education System Improves Insulin Site Rotation Habits: Results of a Randomized Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saint John Regional Hospital; St. Boniface Hospital; Manitoba Hydro; Research Manitoba","funders":"","keywords":"Medicine; Insulin pen; Injection site; Diabetes mellitus; Randomized controlled trial; Insulin; Physical therapy; Surgery; Internal medicine","score_opus":0.01859132040464718,"score_gpt":0.2876809287663831,"score_spread":0.26908960836173595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093021192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352986,0.0008694158,0.00030670973,0.00018322389,0.00011251403,0.003977095,0.0002936063,0.000033047534,0.00069456187],"genre_scores_gemma":[0.993236,0.0012701699,0.0017870973,0.00028521902,0.00011042623,0.0023511248,0.00025209383,0.0000062213544,0.00070169935],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99744415,0.0014614676,0.00018990973,0.0002481008,0.00036773487,0.00028860677],"domain_scores_gemma":[0.99756217,0.0008053814,0.0005562208,0.00016136379,0.00030071207,0.0006141264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030031165,0.00074896275,0.0012258248,0.000386579,0.0004209629,0.0006654076,0.0008491591,0.001171328,0.0044903583],"category_scores_gemma":[0.004812915,0.0004641672,0.0014493701,0.0006952275,0.0007297088,0.00054904417,0.0004193084,0.0011698958,0.0002886213],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.84841985,0.07686266,0.006784662,0.0017525378,0.0026753,0.000063624284,0.00026673207,0.00027039845,0.0017839798,0.00005567798,0.0005408219,0.060523625],"study_design_scores_gemma":[0.6812028,0.27844936,0.036178164,0.00014497274,0.0021036197,0.000032075895,0.00012636538,0.0005255567,0.000572817,0.00006524557,0.0005696521,0.000029306546],"about_ca_topic_score_codex":0.019916782,"about_ca_topic_score_gemma":0.028497547,"teacher_disagreement_score":0.019916782,"about_ca_system_score_codex":0.0020085895,"about_ca_system_score_gemma":0.0032337813,"threshold_uncertainty_score":0.039601684},"labels":[],"label_agreement":null},{"id":"W3114726363","doi":"10.1007/s13300-020-00984-x","title":"Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study","year":2020,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Fraser Health; University of British Columbia","funders":"Novo Nordisk Canada; Novo Nordisk","keywords":"Semaglutide; Dulaglutide; Liraglutide; Medicine; Internal medicine; Tolerability; Type 2 diabetes; Interquartile range; Body mass index; Exenatide; Glycated hemoglobin; Gastroenterology; Type 2 Diabetes Mellitus; Endocrinology; Diabetes mellitus; Adverse effect","score_opus":0.01455503054483066,"score_gpt":0.2668258907390139,"score_spread":0.25227086019418327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3114726363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927521,0.0037988788,0.00068900845,0.00012763315,0.0000263768,0.00026420015,0.0017559932,0.000012615346,0.0005732904],"genre_scores_gemma":[0.9963542,0.00071971165,0.00067621836,0.00010443463,0.000039059036,0.000191286,0.0017820144,0.000006132031,0.00012682214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9903861,0.007074895,0.0007594548,0.0007216275,0.00083016773,0.00022769961],"domain_scores_gemma":[0.9814725,0.007559282,0.008218868,0.0012500925,0.0008783395,0.0006209897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011155165,0.00080172863,0.0015878425,0.00066745124,0.00021836715,0.0012110913,0.00061601296,0.0007543665,0.0011684285],"category_scores_gemma":[0.020680722,0.00048303572,0.0041088364,0.00084903894,0.0004753756,0.00073558686,0.00061982777,0.00095357036,0.000182368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.35490954,0.005830856,0.5099316,0.0030752749,0.049658164,0.000462832,0.0004795478,0.01609336,0.002007093,0.00057341624,0.0023458505,0.054632474],"study_design_scores_gemma":[0.040827673,0.11942379,0.7722608,0.0005662351,0.03151764,0.0014188348,0.0005503375,0.024824897,0.0022052971,0.00057303265,0.0055463137,0.00028514533],"about_ca_topic_score_codex":0.0015467964,"about_ca_topic_score_gemma":0.0015083934,"teacher_disagreement_score":0.011155165,"about_ca_system_score_codex":0.0013349145,"about_ca_system_score_gemma":0.00072686875,"threshold_uncertainty_score":0.05899483},"labels":[],"label_agreement":null},{"id":"W3125665982","doi":"10.1007/s13300-021-01001-5","title":"Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case–Control Study","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Advanced Glycation End Products research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; Lunenfeld-Tanenbaum Research Institute","funders":"Finska Läkaresällskapet; Helsingin ja Uudenmaan Sairaanhoitopiiri","keywords":"Offspring; Medicine; Diabetes mellitus; Type 2 diabetes; Glycated hemoglobin; Cross-sectional study; Population; Type 1 diabetes; Body mass index; Internal medicine; Young adult; Endocrinology; Physiology; Pregnancy; Pathology; Biology","score_opus":0.010792999496902054,"score_gpt":0.2919295167094721,"score_spread":0.28113651721257005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125665982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994562,0.00017378289,0.000070974376,0.000007804252,0.0000038103287,0.000011971332,0.00010576866,0.0000016245948,0.00016805524],"genre_scores_gemma":[0.9993411,0.0001554991,0.000110207344,0.00002484737,0.000008740108,0.00001720482,0.00018436836,0.0000014937667,0.000156539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995053,0.00012178443,0.000052719664,0.00018228788,0.000084296254,0.000053688556],"domain_scores_gemma":[0.9989065,0.00024098277,0.00040273435,0.00014032291,0.0001261869,0.00018325659],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008231767,0.0004190988,0.0004226644,0.00072400767,0.000500613,0.00052525406,0.00030324535,0.0005941641,0.0016461931],"category_scores_gemma":[0.001770582,0.000543878,0.0003872573,0.00070580473,0.00028538404,0.0003149492,0.00028620585,0.00043325944,0.00026589137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016543828,0.00009473648,0.99835974,0.00000985151,0.00007471102,0.00020496108,0.00012581258,0.000007357128,0.00038136938,0.000007824605,0.000034244003,0.0005338961],"study_design_scores_gemma":[0.00001577225,0.00024375375,0.9987897,0.0000052614314,0.000060867693,0.0005725412,0.00011884175,0.00003178243,0.000059642378,0.000006386266,0.00009309654,0.0000023246325],"about_ca_topic_score_codex":0.0044164974,"about_ca_topic_score_gemma":0.004040627,"teacher_disagreement_score":0.0044164974,"about_ca_system_score_codex":0.00022511544,"about_ca_system_score_gemma":0.00016695354,"threshold_uncertainty_score":0.008781552},"labels":[],"label_agreement":null},{"id":"W3134228882","doi":"10.1007/s13300-021-01018-w","title":"Efficacy and Safety of Ertugliflozin in Patients With Diabetes Mellitus Inadequately Controlled by Sulfonylurea Monotherapy: a Substudy of VERTIS CV","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cambridge Cardiac Care Centre","funders":"Merck Sharp and Dohme; Pfizer","keywords":"Medicine; Internal medicine; Cohort; Sulfonylurea; Placebo; Diabetes mellitus; Adverse effect; Gastroenterology; Insulin; Endocrinology","score_opus":0.006761234587167101,"score_gpt":0.2156693836597361,"score_spread":0.208908149072569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3134228882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98803407,0.008034804,0.0001658799,0.00024965155,0.00006794123,0.0005722881,0.0011772304,0.00001814705,0.0016799403],"genre_scores_gemma":[0.9946656,0.0021072396,0.0003646625,0.00035548818,0.00017230128,0.00053132593,0.0014152229,0.0000055006467,0.00038262416],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99725336,0.0014897417,0.00034654597,0.00030005988,0.00037620726,0.00023399931],"domain_scores_gemma":[0.9964683,0.0012658853,0.0010309963,0.00041405746,0.0003206537,0.00050016027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004262066,0.000634663,0.0028914157,0.00050853833,0.00044848677,0.0007811137,0.00050965394,0.0008771912,0.0020337675],"category_scores_gemma":[0.00436973,0.0003126024,0.0026597602,0.0011681948,0.0004447122,0.00047594548,0.0006065805,0.0010847347,0.0002126058],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51183856,0.005144949,0.32013837,0.0043041683,0.025924912,0.0005866822,0.0008852674,0.0012383274,0.01420861,0.00021693853,0.003868013,0.11164521],"study_design_scores_gemma":[0.21350022,0.10595182,0.64969075,0.0005763831,0.019404326,0.0010327077,0.0003334095,0.0014373269,0.0025070403,0.000246357,0.005216567,0.00010313304],"about_ca_topic_score_codex":0.0027324841,"about_ca_topic_score_gemma":0.012612906,"teacher_disagreement_score":0.004262066,"about_ca_system_score_codex":0.0008172106,"about_ca_system_score_gemma":0.000875504,"threshold_uncertainty_score":0.022540212},"labels":[],"label_agreement":null},{"id":"W3157765213","doi":"10.1007/s13300-021-01063-5","title":"Evaluating the Effectiveness of Switching to Insulin Degludec from Other Basal Insulins in a Real-World Canadian Population with Type 1 or Type 2 Diabetes: The CAN-TREAT Study","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; Professional Engineers Ontario; CARE Canada; Custom Security Industries (Canada); Western University","funders":"","keywords":"Insulin degludec; Medicine; Type 2 diabetes; Internal medicine; Insulin; Diabetes mellitus; Population; Basal (medicine); Type 1 diabetes; Basal insulin; Endocrinology","score_opus":0.07191577639952101,"score_gpt":0.38472603548779877,"score_spread":0.31281025908827775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3157765213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923018,0.0032067895,0.00012210652,0.00037592236,0.000036815683,0.00031207883,0.0017148296,0.000011022535,0.0019185154],"genre_scores_gemma":[0.99559635,0.0016293259,0.00044192563,0.0004177232,0.000042329826,0.00009413269,0.0014595966,0.0000047662943,0.00031380105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99662846,0.0011223644,0.00019835144,0.0004204249,0.0011914561,0.0004389721],"domain_scores_gemma":[0.9935801,0.001543688,0.0021825098,0.0003210256,0.0013889675,0.0009836179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047389637,0.00086508907,0.0012376674,0.0005524289,0.0012839742,0.0013222685,0.0013340482,0.0010676516,0.0013164212],"category_scores_gemma":[0.011037473,0.00038674305,0.0022821766,0.0023990383,0.000901674,0.00054889347,0.0005579713,0.0012244566,0.00013456108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07985448,0.00452434,0.8471591,0.0012342382,0.006133786,0.00020518801,0.00057783094,0.0019269584,0.0007178135,0.0002885315,0.003058265,0.054319482],"study_design_scores_gemma":[0.0111515615,0.017084014,0.9588449,0.00024615976,0.0048388764,0.00022489861,0.0007033795,0.003886196,0.00035416867,0.00012936178,0.0024297647,0.000106740416],"about_ca_topic_score_codex":0.80574965,"about_ca_topic_score_gemma":0.85073096,"teacher_disagreement_score":0.19425035,"about_ca_system_score_codex":0.017747708,"about_ca_system_score_gemma":0.017543508,"threshold_uncertainty_score":0.3907886},"labels":[],"label_agreement":null},{"id":"W3192341073","doi":"10.1007/s13300-021-01130-x","title":"Efficacy of a New Protocol of Premixed 70/30 Human Insulin in Haitian Youth with Diabetes","year":2021,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal Children's Hospital","funders":"","keywords":"Medicine; Insulin; Diabetes mellitus; Evening; Interquartile range; Morning; Internal medicine; Regular insulin; NPH insulin; Type 2 diabetes; Endocrinology; Hypoglycemia; Insulin glargine","score_opus":0.03840790414353538,"score_gpt":0.32266631259867856,"score_spread":0.28425840845514316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3192341073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942484,0.00028329005,0.000506554,0.00010261857,0.00007123021,0.003729544,0.00012698644,0.000049945997,0.00088143325],"genre_scores_gemma":[0.98639673,0.00036068758,0.0055921576,0.00030563827,0.00008365852,0.0062524555,0.0002939488,0.000008040763,0.0007066491],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99858487,0.00075843773,0.0001835554,0.00018634147,0.00018007348,0.000106736],"domain_scores_gemma":[0.99850285,0.0004387232,0.00038606828,0.00021268992,0.000102831196,0.00035686386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031024755,0.00061662914,0.0010056185,0.00040543906,0.00044766266,0.00037930429,0.000842204,0.00078983395,0.003182939],"category_scores_gemma":[0.003290334,0.00036088182,0.0008129454,0.0004301364,0.0004462337,0.0004304545,0.0006484301,0.0010823425,0.00034072853],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.57141984,0.1195384,0.017271003,0.0010468488,0.0006234609,0.000105995314,0.0005270073,0.0019348209,0.0051930356,0.00023456677,0.000986545,0.28111848],"study_design_scores_gemma":[0.20559682,0.687939,0.09631315,0.00021077182,0.00053865963,0.00013312737,0.0002467934,0.0029639888,0.0034154335,0.00015903931,0.0024279004,0.00005538345],"about_ca_topic_score_codex":0.002379622,"about_ca_topic_score_gemma":0.0024441574,"teacher_disagreement_score":0.003182939,"about_ca_system_score_codex":0.00074788614,"about_ca_system_score_gemma":0.0014903395,"threshold_uncertainty_score":0.016407669},"labels":[],"label_agreement":null},{"id":"W4213359410","doi":"10.1007/s13300-015-0124-0","title":"Erratum to: Associations Between Glycemic Control, Depressed Mood, Clinical Depression, and Diabetes Distress Before and After Insulin Initiation: An Exploratory, Post Hoc Analysis","year":2015,"lang":"en","type":"erratum","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Glycemic; Medicine; Distress; Diabetes mellitus; Depression (economics); Post-hoc analysis; Mood; Insulin; Psychiatry; Internal medicine; Clinical psychology; Endocrinology","score_opus":0.028419742418816205,"score_gpt":0.3313829894486,"score_spread":0.3029632470297838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213359410","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009604512,0.0040271077,0.0022215075,0.08018505,0.8706027,0.0003722935,0.025083028,0.0005616794,0.0073422007],"genre_scores_gemma":[0.17346755,0.011585665,0.023171399,0.26484528,0.13394381,0.0023459329,0.042945143,0.002426161,0.34526914],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966292,0.00086635625,0.0009649016,0.0003580616,0.0009715754,0.00020981334],"domain_scores_gemma":[0.9537513,0.027834332,0.002838627,0.0016753954,0.013028129,0.00087223866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046574525,0.0013088855,0.0013889875,0.0019779473,0.0016827632,0.0013222598,0.0015309667,0.001962855,0.046362683],"category_scores_gemma":[0.07810457,0.0006274144,0.0020760708,0.0016231849,0.0006444133,0.0012299048,0.0006868565,0.002675136,0.0103465635],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058930006,0.00006151168,0.0041290433,0.00035934904,0.00010263701,0.0003724333,0.000048822156,0.0000931339,0.000050049675,0.00032007773,0.9853361,0.008537544],"study_design_scores_gemma":[0.0022417177,0.0012531404,0.108687736,0.0043040034,0.0020287682,0.0034089917,0.0019384027,0.001911218,0.0015397801,0.0041965437,0.868153,0.00033676805],"about_ca_topic_score_codex":0.017581586,"about_ca_topic_score_gemma":0.03031475,"teacher_disagreement_score":0.046362683,"about_ca_system_score_codex":0.0015155287,"about_ca_system_score_gemma":0.0035222769,"threshold_uncertainty_score":0.15509856},"labels":[],"label_agreement":null},{"id":"W4214539958","doi":"10.1007/s13300-022-01216-0","title":"Defining Minimum Necessary Communication During Care Transitions for Patients on Antihyperglycemic Medication: Consensus of the Care Transitions Task Force of the IPRO Hypoglycemia Coalition","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"National Institute on Aging; National Institute of Diabetes and Digestive and Kidney Diseases; Abbott Diabetes Care; Centers for Medicare and Medicaid Services; U.S. Department of Veterans Affairs; Syracuse University; Centers for Disease Control and Prevention","keywords":"Task (project management); Hypoglycemia; Medicine; Task force; Diabetes mellitus; Patient care; Intensive care medicine; Nursing; Public administration; Political science; Management; Endocrinology","score_opus":0.00876583446230965,"score_gpt":0.24807951298817388,"score_spread":0.23931367852586422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214539958","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16254386,0.012379219,0.07300441,0.6576784,0.010063874,0.031364784,0.0017322733,0.00075095537,0.050482288],"genre_scores_gemma":[0.6278219,0.013856484,0.23894376,0.060103744,0.0035031252,0.04269579,0.004527144,0.00055826927,0.0079897605],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.78501415,0.11424223,0.04134926,0.0069523826,0.03742315,0.015018835],"domain_scores_gemma":[0.6069847,0.16414836,0.033523455,0.013691794,0.1406052,0.04104653],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.3022016,0.0012503267,0.0020026022,0.007662995,0.013231243,0.009131736,0.007581652,0.006601053,0.0026347071],"category_scores_gemma":[0.2954226,0.0015598773,0.0035384644,0.0033419745,0.0050447225,0.0077104634,0.02834829,0.0129926745,0.0008388474],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053709693,0.0014966886,0.05924727,0.012092274,0.00058436696,0.0020259642,0.1523528,0.0034403012,0.0040942095,0.019365516,0.23441307,0.5103504],"study_design_scores_gemma":[0.0007799099,0.0019081953,0.08333402,0.036631357,0.000592528,0.0018748948,0.2361439,0.0077059357,0.004723018,0.027292019,0.5979552,0.0010590309],"about_ca_topic_score_codex":0.02085164,"about_ca_topic_score_gemma":0.021147951,"teacher_disagreement_score":0.3022016,"about_ca_system_score_codex":0.021448173,"about_ca_system_score_gemma":0.20306514,"threshold_uncertainty_score":0.86050963},"labels":[],"label_agreement":null},{"id":"W4220773185","doi":"10.1007/s13300-022-01247-7","title":"Clinical Use of Insulin Glargine 300 U/mL in Adults with Type 2 Diabetes: Hypothetical Case Studies","year":2022,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Sanofi","keywords":"Medicine; Insulin glargine; Basal insulin; Insulin; Context (archaeology); Hypoglycemia; Diabetes mellitus; Basal (medicine); Type 2 diabetes; Internal medicine; Endocrinology; Intensive care medicine","score_opus":0.2005561795537173,"score_gpt":0.42984573758603817,"score_spread":0.22928955803232087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220773185","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010168565,0.99698824,0.00010190252,0.00042388865,0.00012234041,0.000017251881,0.000017400827,0.0000017359115,0.0013104124],"genre_scores_gemma":[0.009983032,0.9884603,0.00050276046,0.0005910152,0.00015521265,0.000021414065,0.000030163555,0.0000012239154,0.0002548493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9992187,0.00036324127,0.00018959556,0.00007466677,0.000120720986,0.00003311432],"domain_scores_gemma":[0.9979444,0.0015716659,0.00030075904,0.000035114288,0.00011366856,0.000034443525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015072813,0.0004879294,0.0009479355,0.0011503417,0.000249349,0.00082083076,0.00066193426,0.0014780168,0.0026263488],"category_scores_gemma":[0.00433337,0.0001848057,0.001003056,0.0017833513,0.00044534702,0.000796913,0.00034395847,0.000854561,0.00044286478],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005267221,0.00015342163,0.0023562347,0.11741907,0.0006675724,0.012224346,0.00050883234,0.00043079836,0.0007209428,0.005276256,0.019616237,0.84009945],"study_design_scores_gemma":[0.00030221406,0.00064757635,0.009691328,0.1406397,0.0043885564,0.12838893,0.0015225008,0.00043884682,0.0010694939,0.004916497,0.7078724,0.00012189586],"about_ca_topic_score_codex":0.0011613524,"about_ca_topic_score_gemma":0.0023837006,"teacher_disagreement_score":0.0026263488,"about_ca_system_score_codex":0.0004232708,"about_ca_system_score_gemma":0.0007197576,"threshold_uncertainty_score":0.008786023},"labels":[],"label_agreement":null},{"id":"W4220787584","doi":"10.1007/s13300-022-01213-3","title":"Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Swedish Orphan Biovitrum; Dexcom; Novo Nordisk; Sanofi; Servier; Amgen; Pfizer; AstraZeneca; Daiichi Sankyo Europe; Eli Lilly and Company; GlaxoSmithKline","keywords":"Insulin aspart; Medicine; Postprandial; Post-hoc analysis; Internal medicine; Type 2 diabetes; Insulin; Diabetes mellitus; Endocrinology","score_opus":0.007433118407592998,"score_gpt":0.253035676854968,"score_spread":0.24560255844737497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220787584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878762,0.0062409043,0.00070402405,0.00036172048,0.0005355958,0.0013717641,0.0013024694,0.000059759175,0.0015476748],"genre_scores_gemma":[0.9908557,0.0017272893,0.0012198237,0.0004983311,0.00038189502,0.0020298632,0.0013238675,0.00003112672,0.0019320515],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99757534,0.0016455526,0.00017884302,0.0002542851,0.00010483651,0.00024105328],"domain_scores_gemma":[0.9973912,0.0012152749,0.00054082496,0.00024603217,0.00016477352,0.00044182607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040241843,0.0015366274,0.0049362327,0.000250774,0.00033120348,0.0013185561,0.0006763132,0.0010330392,0.003540942],"category_scores_gemma":[0.0033854335,0.0004308769,0.0057004155,0.0003708689,0.00060655473,0.001096694,0.0006452974,0.0029082417,0.00039843676],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9914095,0.0005972056,0.00061690854,0.00030960317,0.0025705157,0.00002273334,0.000027974893,0.00013776396,0.0006938639,0.000038515438,0.00021908956,0.0033563343],"study_design_scores_gemma":[0.9177457,0.06860739,0.0067215073,0.000067283436,0.005022598,0.000038078528,0.000052321895,0.00042537844,0.0004615879,0.00019377083,0.00063985586,0.000024527339],"about_ca_topic_score_codex":0.000648895,"about_ca_topic_score_gemma":0.0014813176,"teacher_disagreement_score":0.0049362327,"about_ca_system_score_codex":0.00054456893,"about_ca_system_score_gemma":0.0009270705,"threshold_uncertainty_score":0.021282136},"labels":[],"label_agreement":null},{"id":"W4220897970","doi":"10.1007/s13300-022-01231-1","title":"Exploring a Suitable Marker of Glycemic Response to Dulaglutide in Patients with Type 2 Diabetes: A Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Japan Society for the Promotion of Science","keywords":"Dulaglutide; Glycemic; Medicine; Internal medicine; Postprandial; Diabetes mellitus; Type 2 diabetes; Confounding; Endocrinology; Insulin; Liraglutide","score_opus":0.025611590432546776,"score_gpt":0.24125545096083223,"score_spread":0.21564386052828546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220897970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988494,0.000528237,0.0002286842,0.000015198122,0.0000044287976,0.000010724629,0.00015466407,0.00000209398,0.00020658833],"genre_scores_gemma":[0.99943537,0.0001500712,0.00012244798,0.000019641084,0.000007374881,0.000009075723,0.00021913,0.0000014781107,0.000035364974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923337,0.00024419668,0.00013933373,0.00021154048,0.00010386299,0.000067661356],"domain_scores_gemma":[0.9982591,0.00040571397,0.0007059122,0.00026285273,0.00017082554,0.00019556521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001317872,0.00026907146,0.0004373732,0.00070029724,0.00047710878,0.0006823156,0.00034470414,0.0003650977,0.000715046],"category_scores_gemma":[0.0019187871,0.0003055018,0.00058869354,0.0013425255,0.0003220924,0.0006064704,0.00035241575,0.00040805497,0.0001792948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067061235,0.000008451927,0.9994814,0.000003356994,0.000021699876,0.000040663024,0.000016296206,0.000008862418,0.00006281098,0.0000041387966,0.000007802752,0.00027761012],"study_design_scores_gemma":[0.000010875511,0.00024894733,0.9982374,0.000007576374,0.00008326223,0.00066087133,0.00018825934,0.00020289444,0.00013031144,0.000016704598,0.00020750082,0.0000054113643],"about_ca_topic_score_codex":0.0019461873,"about_ca_topic_score_gemma":0.0017195867,"teacher_disagreement_score":0.0019461873,"about_ca_system_score_codex":0.00023972068,"about_ca_system_score_gemma":0.00029536686,"threshold_uncertainty_score":0.0069696903},"labels":[],"label_agreement":null},{"id":"W4310350904","doi":"10.1007/s13300-022-01346-5","title":"Sustained Improvement in Glycemic Control in Emerging Adults with Type 1 Diabetes 2 Years After the Start of the COVID-19 Pandemic","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"University of Toronto","keywords":"Medicine; Glycemic; Pandemic; Diabetes mellitus; Type 2 diabetes; Coronavirus disease 2019 (COVID-19); Type 1 diabetes; Diabetes management; Young adult; Public health; Referral; Internal medicine; Pediatrics; Emergency medicine; Disease; Endocrinology; Family medicine; Infectious disease (medical specialty)","score_opus":0.012556922968457175,"score_gpt":0.26641797842853226,"score_spread":0.2538610554600751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310350904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99936527,0.00016795855,0.000019126806,0.00003757482,0.0000049537093,0.000005002719,0.000114996496,0.0000011868578,0.0002838863],"genre_scores_gemma":[0.9994815,0.00012160236,0.000025472154,0.0000413338,0.0000081548105,0.000003069838,0.00023034164,5.795415e-7,0.00008805482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99970573,0.00004878173,0.000033192857,0.000060959086,0.000053594445,0.00009764645],"domain_scores_gemma":[0.9988764,0.00009439454,0.0005058364,0.000046633777,0.00019321643,0.00028350993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046126847,0.00015656589,0.00032278374,0.00041284354,0.000547135,0.0006937343,0.0002501221,0.00040241197,0.00045555856],"category_scores_gemma":[0.001882322,0.00014676481,0.00026915458,0.00054546533,0.00022034778,0.00046785758,0.00037854223,0.00066666293,0.00007958204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007924527,0.000035940815,0.99808013,0.000005700003,0.0000109243965,0.00019043394,0.00019876486,0.00001372269,0.00009950482,0.0000038600015,0.000051280662,0.0012304449],"study_design_scores_gemma":[0.000001693853,0.00008398811,0.99937844,0.0000051879383,0.0000049314367,0.00011894322,0.00032447957,0.00001918581,0.000018967443,0.0000023093726,0.00004024981,0.000001561247],"about_ca_topic_score_codex":0.046873845,"about_ca_topic_score_gemma":0.07724431,"teacher_disagreement_score":0.046873845,"about_ca_system_score_codex":0.0007566304,"about_ca_system_score_gemma":0.00054203253,"threshold_uncertainty_score":0.093201995},"labels":[],"label_agreement":null},{"id":"W4312211549","doi":"10.1007/s13300-022-01353-6","title":"Ease of Use of the iGlarLixi SoloStar Pen from the LixiLan ONE CAN Pen Sub-Study: Questionnaire Findings from People Living with Type 2 Diabetes and Their HealthCare Providers","year":2022,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Western University; McMaster University; Sanofi (Canada); McGill University Health Centre","funders":"Sanofi","keywords":"Medicine; Health care; Nursing; Gerontology; Family medicine; Internet privacy; Computer science","score_opus":0.026664615773109097,"score_gpt":0.2471243322216852,"score_spread":0.2204597164485761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312211549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904028,0.0010055738,0.00028493433,0.00024216539,0.000037322956,0.001348234,0.0030357463,0.000012671834,0.0036304567],"genre_scores_gemma":[0.9911266,0.0009579828,0.00095814635,0.00068762485,0.000051223284,0.0023101734,0.002400011,0.0000147908195,0.0014934089],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99669904,0.0014291089,0.00054278766,0.00025816428,0.0008344047,0.0002364769],"domain_scores_gemma":[0.992222,0.0026866095,0.0031718232,0.00029745753,0.0009711824,0.000650889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058754706,0.00042140792,0.0010193741,0.0005557463,0.00046759364,0.0010124564,0.0004569357,0.00063448184,0.004870719],"category_scores_gemma":[0.009161931,0.0002679198,0.0019226465,0.0007469495,0.00040185705,0.0011472693,0.0010827271,0.0011355209,0.00060491916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01875974,0.0071228095,0.86840856,0.004065443,0.0035041776,0.00043457997,0.0043665147,0.0005160747,0.0011370044,0.00018662,0.008583333,0.08291516],"study_design_scores_gemma":[0.0026666918,0.013190662,0.9694519,0.00047765343,0.0010124121,0.0007372218,0.00356174,0.0006347366,0.0005607266,0.00015359015,0.007462962,0.00008958664],"about_ca_topic_score_codex":0.0019704613,"about_ca_topic_score_gemma":0.002593244,"teacher_disagreement_score":0.0058754706,"about_ca_system_score_codex":0.00059410103,"about_ca_system_score_gemma":0.00067481154,"threshold_uncertainty_score":0.031072795},"labels":[],"label_agreement":null},{"id":"W4323920834","doi":"10.1007/s13300-023-01389-2","title":"Correlation Between Time in Range and HbA1c in People with Type 2 Diabetes on Basal Insulin: Post Hoc Analysis of the SWITCH PRO Study","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"Novo Nordisk","keywords":"Medicine; Basal (medicine); Post-hoc analysis; Type 2 diabetes; Diabetes mellitus; Basal insulin; Insulin; Post hoc; Internal medicine; Endocrinology","score_opus":0.018606087282138563,"score_gpt":0.2811965862677894,"score_spread":0.2625904989856508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323920834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985481,0.00022005913,0.00035812272,0.000019396466,0.000036568144,0.00007380089,0.00037104447,0.000010792537,0.0003620768],"genre_scores_gemma":[0.9984542,0.00005012299,0.00028376712,0.000028198649,0.000037307826,0.00015285418,0.0005815614,0.000009649364,0.00040237064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961754,0.0024785697,0.00019804433,0.0005188905,0.00038452318,0.00024452133],"domain_scores_gemma":[0.9931767,0.003761894,0.0011525087,0.00097262964,0.00054750143,0.00038884836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054131504,0.00062138156,0.0012401012,0.0004509204,0.00023183337,0.00067882903,0.0005072356,0.00043235812,0.0012413309],"category_scores_gemma":[0.0062829643,0.00027626666,0.0023661612,0.00054314133,0.00027194867,0.0005396987,0.00058047776,0.0010524482,0.00019460428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.17231825,0.0010892198,0.79895365,0.0003062411,0.0079893675,0.0003230372,0.00049222755,0.0007568536,0.0031462628,0.000108972,0.0010942437,0.0134217],"study_design_scores_gemma":[0.0015594333,0.018350746,0.97354615,0.000015896596,0.0022972256,0.00010839643,0.00024554008,0.0023519015,0.0006639219,0.00007479892,0.0007603725,0.000025534066],"about_ca_topic_score_codex":0.00075814466,"about_ca_topic_score_gemma":0.00086161995,"teacher_disagreement_score":0.0054131504,"about_ca_system_score_codex":0.00019505904,"about_ca_system_score_gemma":0.00038802318,"threshold_uncertainty_score":0.028627813},"labels":[],"label_agreement":null},{"id":"W4377011531","doi":"10.1007/s13300-023-01418-0","title":"Guardians For Health: A Practical Approach to Improving Quality of Life and Longevity in People with Type 2 Diabetes","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Manitoba; Dalhousie University","funders":"Boehringer Ingelheim; Yale University","keywords":"Medicine; Guideline; Type 2 diabetes; Diabetes mellitus; Disease; Intensive care medicine; Quality of life (healthcare); Health care; MEDLINE; Gerontology; Family medicine; Nursing; Internal medicine; Pathology","score_opus":0.5492886206901549,"score_gpt":0.5077282750631176,"score_spread":0.041560345627037365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377011531","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019927513,0.9734272,0.0013582711,0.020881772,0.00079256727,0.00009138101,0.000062103514,0.000028045526,0.0031594937],"genre_scores_gemma":[0.0058551626,0.97355485,0.008240913,0.00977738,0.00082378834,0.00025786433,0.00008601337,0.000013097618,0.0013909923],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9963941,0.0022650328,0.00038709733,0.00014628578,0.00070518156,0.00010223483],"domain_scores_gemma":[0.99434763,0.0043912856,0.0004878831,0.00012491933,0.00047273186,0.0001754894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007754018,0.0012116849,0.0020099576,0.0034323204,0.000495974,0.0024310146,0.0012712077,0.003710112,0.0069768163],"category_scores_gemma":[0.015321907,0.00040600318,0.001726994,0.0027734123,0.00115928,0.0029707092,0.0019490534,0.005373259,0.0010200945],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007029316,0.00008947983,0.00030810112,0.041015532,0.00051707966,0.00012965513,0.00038307,0.0002963641,0.00012473439,0.03605035,0.06987564,0.8511398],"study_design_scores_gemma":[0.00018770935,0.00013260209,0.0016319664,0.107233696,0.00070635683,0.0006195912,0.00043349416,0.00032478056,0.00015378914,0.03478423,0.85375065,0.000041142473],"about_ca_topic_score_codex":0.0033413917,"about_ca_topic_score_gemma":0.007871823,"teacher_disagreement_score":0.007754018,"about_ca_system_score_codex":0.0020965103,"about_ca_system_score_gemma":0.0063802805,"threshold_uncertainty_score":0.041007638},"labels":[],"label_agreement":null},{"id":"W4378783299","doi":"10.1007/s13300-023-01413-5","title":"Greater Combined Reductions of HbA1c ≥ 1.0% and Body Weight Loss ≥ 5.0% or ≥ 10.0% with Orally Administered Semaglutide Versus Comparators","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"Novo Nordisk; Steno Diabetes Center Copenhagen","keywords":"Semaglutide; Liraglutide; Medicine; Empagliflozin; Sitagliptin; Weight loss; Placebo; Type 2 diabetes; Internal medicine; Diabetes mellitus; Endocrinology; Obesity","score_opus":0.03918269970728713,"score_gpt":0.28839835964490207,"score_spread":0.24921565993761494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378783299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96150565,0.021584159,0.002298041,0.0007729333,0.0007549221,0.0024233053,0.002344987,0.00016848075,0.008147543],"genre_scores_gemma":[0.9889535,0.003384548,0.0022689314,0.0005818446,0.00033184295,0.0011718865,0.0011147205,0.000020931857,0.0021718175],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9956915,0.0028952183,0.00040881857,0.00043108992,0.0003541142,0.00021934674],"domain_scores_gemma":[0.9966556,0.0020946213,0.00057745364,0.00018418707,0.0001923595,0.00029578796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067343507,0.0011531024,0.0054979995,0.0006967852,0.00018978852,0.001038048,0.00047467914,0.0012656352,0.006775265],"category_scores_gemma":[0.0044580977,0.0004467649,0.0062733493,0.0006529416,0.00065126794,0.0013415094,0.0005554209,0.0025823666,0.00051484175],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.94650215,0.0017658995,0.002907392,0.0027399764,0.009498034,0.000078706245,0.000054264314,0.0007271215,0.0052006305,0.0003269291,0.0008797369,0.029319098],"study_design_scores_gemma":[0.6021422,0.30101424,0.055193942,0.0006799639,0.025377916,0.00031982653,0.00012950102,0.0023413128,0.0048139677,0.0017019213,0.0061915405,0.0000936651],"about_ca_topic_score_codex":0.00057510345,"about_ca_topic_score_gemma":0.0016871104,"teacher_disagreement_score":0.006775265,"about_ca_system_score_codex":0.0004812034,"about_ca_system_score_gemma":0.00068754377,"threshold_uncertainty_score":0.035615087},"labels":[],"label_agreement":null},{"id":"W4379260635","doi":"10.1007/s13300-023-01423-3","title":"Real-World Effects of Second-Generation Versus Earlier Intermediate/Basal Insulin Analogues on Rates of Hypoglycemia in Adults with Type 1 and 2 Diabetes (iNPHORM, US)","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials; Western University","funders":"Sanofi Pasteur","keywords":"Medicine; Hypoglycemia; Basal (medicine); Diabetes mellitus; Basal insulin; Internal medicine; Insulin; Type 1 diabetes; Endocrinology; Type 2 diabetes","score_opus":0.023049317534895943,"score_gpt":0.2940169029136934,"score_spread":0.2709675853787975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379260635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966961,0.0005742501,0.00026707991,0.00016628041,0.000024178908,0.000030217036,0.0018393669,0.000010104725,0.00039240255],"genre_scores_gemma":[0.9978897,0.00022641584,0.00028108957,0.00013156385,0.00001637719,0.000038233266,0.001290126,0.0000034193772,0.00012306988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99657166,0.002351533,0.00015767998,0.00051924615,0.00021790902,0.00018202885],"domain_scores_gemma":[0.9874905,0.0063517746,0.0041826135,0.0009800687,0.00032022037,0.00067485863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007406452,0.00040004074,0.00052195485,0.00031385513,0.00017773818,0.00083143194,0.00054635305,0.0005826204,0.0018917954],"category_scores_gemma":[0.015974877,0.00028118028,0.0021614856,0.0005693541,0.00023728707,0.0005768814,0.00085647544,0.0009373079,0.00016163533],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0088269785,0.00036390775,0.9781657,0.00014089882,0.0016415078,0.000051381478,0.000102424776,0.0016546056,0.00010782214,0.00009060383,0.0006710915,0.008183127],"study_design_scores_gemma":[0.00032429956,0.0030470064,0.9902019,0.00006870435,0.0008245675,0.000113319824,0.0001292578,0.004562229,0.00013923683,0.00013632841,0.00043629477,0.000016939917],"about_ca_topic_score_codex":0.008515498,"about_ca_topic_score_gemma":0.005828013,"teacher_disagreement_score":0.008515498,"about_ca_system_score_codex":0.00046241115,"about_ca_system_score_gemma":0.00041091905,"threshold_uncertainty_score":0.03916955},"labels":[],"label_agreement":null},{"id":"W4381105997","doi":"10.1007/s13300-023-01429-x","title":"Healthcare Professionals’ Knowledge of and Attitudes Towards the Use of Time in Range in Diabetes Management: Online Survey Across Seven Countries","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Hyperglycemia and glycemic control in critically ill and hospitalized patients","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Novo Nordisk","keywords":"Medicine; Diabetes mellitus; Health professionals; Diabetes management; Family medicine; Regimen; Health care; Nursing; Type 2 diabetes; Internal medicine","score_opus":0.07840912946528061,"score_gpt":0.3713349090589144,"score_spread":0.2929257795936338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381105997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980977,0.00016873227,0.00008502859,0.00031523604,0.000008097681,0.0000508399,0.00030587692,0.000002482965,0.0009659751],"genre_scores_gemma":[0.998317,0.00036874774,0.00032878996,0.00052267464,0.0000087710605,0.000069785594,0.00020951347,0.0000022999168,0.00017244976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99655885,0.0015628976,0.00051481026,0.0003091333,0.00054510415,0.0005092861],"domain_scores_gemma":[0.9868379,0.0048381137,0.0039108344,0.0003845437,0.0022734194,0.0017551688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044444916,0.00018941809,0.0003995447,0.0009921537,0.0005776574,0.0010147787,0.00026732017,0.00067037635,0.0014550595],"category_scores_gemma":[0.010560818,0.00035835584,0.00040808943,0.0013356698,0.00058977597,0.0009088507,0.0011795543,0.00068414886,0.00029040274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008721024,0.00020165679,0.9705247,0.00020645253,0.00004790285,0.00025201356,0.014367073,0.000064702064,0.00030285062,0.00004370152,0.00096335076,0.012938396],"study_design_scores_gemma":[0.00002339586,0.0003146098,0.9634946,0.00023528132,0.000029969056,0.0003611449,0.032762982,0.00024610214,0.00014804277,0.000033616703,0.0023312008,0.000019085186],"about_ca_topic_score_codex":0.0082005905,"about_ca_topic_score_gemma":0.0070717833,"teacher_disagreement_score":0.0082005905,"about_ca_system_score_codex":0.0007438184,"about_ca_system_score_gemma":0.001156137,"threshold_uncertainty_score":0.023505032},"labels":[],"label_agreement":null},{"id":"W4382182323","doi":"10.1007/s13300-023-01436-y","title":"The Hidden Burden—Exploring Depression Risk in Patients with Diabetic Nephropathy: A Systematic Review and Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetic nephropathy; Diabetes mellitus; Observational study; Nephropathy; Meta-analysis; Internal medicine; Odds ratio; Depression (economics); Randomized controlled trial; Type 2 diabetes; Confidence interval; Endocrinology","score_opus":0.085483647586891,"score_gpt":0.31659712898750236,"score_spread":0.23111348140061136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4382182323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0046296897,0.9935169,0.0006388509,0.00021661569,0.00015048798,0.00025176143,0.00040605318,0.000019334293,0.00017033699],"genre_scores_gemma":[0.21250132,0.77962744,0.003767966,0.0011237955,0.00037129046,0.0013397961,0.0009295793,0.000030282305,0.00030847124],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98544955,0.008271783,0.003482943,0.0011756878,0.0012634953,0.0003565705],"domain_scores_gemma":[0.9784057,0.016405247,0.0028749905,0.0007000526,0.001345402,0.00026860173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015850017,0.0026217988,0.018392257,0.007886961,0.00072020525,0.003483717,0.0019510903,0.0022590507,0.0025289261],"category_scores_gemma":[0.03360566,0.0016933267,0.041067738,0.007821726,0.0006618907,0.0018504566,0.0018662873,0.0018649065,0.00020823262],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010670089,0.00002072695,0.005894654,0.26044026,0.72241384,0.00013137469,0.00007911268,0.000448451,0.00015378853,0.00012209109,0.0004411331,0.008787592],"study_design_scores_gemma":[0.00031042146,0.000119525284,0.0037768022,0.020293063,0.9739095,0.00009911678,0.0000384159,0.0002351949,0.000071988,0.00017754492,0.00094842725,0.000019992804],"about_ca_topic_score_codex":0.0076690386,"about_ca_topic_score_gemma":0.016870527,"teacher_disagreement_score":0.018392257,"about_ca_system_score_codex":0.0025053178,"about_ca_system_score_gemma":0.0036944202,"threshold_uncertainty_score":0.08382392},"labels":[],"label_agreement":null},{"id":"W4386945140","doi":"10.1007/s13300-023-01468-4","title":"Insulin Therapy for the Management of Diabetes Mellitus: A Narrative Review of Innovative Treatment Strategies","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Insulin; Diabetes mellitus; Intensive care medicine; Type 2 diabetes; Type 2 Diabetes Mellitus; Dosing; Internal medicine; Endocrinology","score_opus":0.11174396295785947,"score_gpt":0.41557464660919746,"score_spread":0.303830683651338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386945140","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040885378,0.9992681,0.00004644914,0.00015926355,0.00009796917,0.000005558828,0.000011523621,0.0000023686425,0.0003677923],"genre_scores_gemma":[0.00026309123,0.99927264,0.00012347112,0.00012952874,0.000089826644,0.0000062729528,0.000013724654,6.974642e-7,0.000100780926],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995122,0.000116585856,0.00011621287,0.00006767875,0.00015771929,0.000029636696],"domain_scores_gemma":[0.99883515,0.00081759924,0.00015334884,0.000020479863,0.00013811213,0.000035273024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010089148,0.0009647332,0.0015320443,0.0034534743,0.00033199758,0.0014255029,0.0008985799,0.0009629582,0.004579819],"category_scores_gemma":[0.0022181915,0.00027609445,0.0011144286,0.003221089,0.0004489515,0.0013462387,0.0007398577,0.0018096459,0.0011598296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010267234,0.0000785803,0.00015984886,0.09217505,0.0002572414,0.00019188909,0.00014728594,0.00027273197,0.00050699536,0.0042341785,0.027283384,0.8745901],"study_design_scores_gemma":[0.000041572202,0.00015733657,0.0009141072,0.0674088,0.00065226137,0.0017052537,0.00013489422,0.00012450574,0.0002091675,0.002901177,0.92571694,0.000034024666],"about_ca_topic_score_codex":0.0013063772,"about_ca_topic_score_gemma":0.002242086,"teacher_disagreement_score":0.004579819,"about_ca_system_score_codex":0.0006984613,"about_ca_system_score_gemma":0.0015964166,"threshold_uncertainty_score":0.015321016},"labels":[],"label_agreement":null},{"id":"W4387033802","doi":"10.1007/s13300-023-01464-8","title":"Humanistic and Economic Burden of Patients with Cardiorenal Metabolic Conditions: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Eli Lilly and Company; Boehringer Ingelheim","keywords":"Medicine; Population; MEDLINE; Health care; Ethnic group; Disease burden; Intensive care medicine; Gerontology; Environmental health","score_opus":0.024788245640435684,"score_gpt":0.3097358291103745,"score_spread":0.2849475834699388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387033802","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028028986,0.99452895,0.00015779889,0.00066798227,0.000113789836,0.00022828604,0.0010285891,0.0000067640203,0.00046487324],"genre_scores_gemma":[0.0649005,0.93192196,0.0008312293,0.0008957338,0.00016594774,0.0006147977,0.0005544238,0.000007795752,0.00010763982],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9834236,0.007791574,0.004987851,0.0009437174,0.002498183,0.0003550935],"domain_scores_gemma":[0.9245212,0.059340104,0.01149564,0.0008084876,0.0033495466,0.00048498544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0139780445,0.0011653429,0.006891051,0.008178826,0.0004989148,0.003152434,0.0013793528,0.0014407762,0.0035350416],"category_scores_gemma":[0.07143577,0.0009327187,0.007558761,0.010104729,0.0009249076,0.002077048,0.0013714104,0.0010976796,0.0001622024],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031833755,0.000014175771,0.00464478,0.92572635,0.037395366,0.0001257381,0.00019127785,0.00018390891,0.000052097083,0.00038136623,0.0025115644,0.028454999],"study_design_scores_gemma":[0.00049981667,0.00018247686,0.017498478,0.8105832,0.15455793,0.00060094567,0.0003523165,0.00023230712,0.00012557297,0.00092076184,0.0143850995,0.000061155275],"about_ca_topic_score_codex":0.00979409,"about_ca_topic_score_gemma":0.022378959,"teacher_disagreement_score":0.0139780445,"about_ca_system_score_codex":0.003968221,"about_ca_system_score_gemma":0.009657935,"threshold_uncertainty_score":0.073923886},"labels":[],"label_agreement":null},{"id":"W4387219824","doi":"10.1007/s13300-023-01479-1","title":"Addressing Insulin Injection Technique: A Follow-up Study of Canadian Patients with Diabetes","year":2023,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Communications Research Centre Canada; Cégep Saint-Jean-sur-Richelieu","funders":"","keywords":"Medicine; Diabetes mellitus; Insulin; Insulin pen; Diabetes management; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.027037812368847558,"score_gpt":0.2688425599392266,"score_spread":0.24180474757037906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387219824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971571,0.0002233205,0.00004909847,0.00025436352,0.000009746771,0.00014526269,0.00095963205,0.000005086375,0.0011964081],"genre_scores_gemma":[0.9969195,0.0003738888,0.0003185141,0.0003531921,0.00000857397,0.00008130141,0.0011500337,0.0000050294675,0.0007900467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987319,0.000090556496,0.00007067211,0.00013938805,0.00052027794,0.0004470849],"domain_scores_gemma":[0.9959849,0.00019346502,0.0005445949,0.00009327731,0.0023004038,0.00088334456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012586981,0.0003692658,0.0007157367,0.0011546649,0.0053661917,0.0013080792,0.0009579445,0.0007919144,0.0017022127],"category_scores_gemma":[0.003035508,0.00046291546,0.00088654284,0.0032695837,0.00057564996,0.00061056874,0.0009120444,0.0015307596,0.0004050682],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011375597,0.00034000372,0.9893505,0.000049559003,0.00002499073,0.00017140934,0.0036306065,0.000025096437,0.00014436398,0.000022242502,0.0007218626,0.0054055112],"study_design_scores_gemma":[0.000020284018,0.00018369396,0.9943931,0.00003229448,0.00002179913,0.0000809366,0.0044034463,0.0000940139,0.000042452237,0.00000826515,0.0007055597,0.000014135942],"about_ca_topic_score_codex":0.9513287,"about_ca_topic_score_gemma":0.96354306,"teacher_disagreement_score":0.048671305,"about_ca_system_score_codex":0.021067427,"about_ca_system_score_gemma":0.021970138,"threshold_uncertainty_score":0.15285558},"labels":[],"label_agreement":null},{"id":"W4390913863","doi":"10.1007/s13300-023-01528-9","title":"Impact of Living with Stigma in Persons with Type 1 Diabetes: A Patient–Physician Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Obesity and Health Practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre; University of Toronto","funders":"","keywords":"Medicine; Type 1 diabetes; Stigma (botany); Psychosocial; Quality of life (healthcare); Prejudice (legal term); Shame; Distress; Social stigma; Mental health; Psychiatry; Clinical psychology; Psychology; Diabetes mellitus; Social psychology; Human immunodeficiency virus (HIV); Family medicine; Nursing","score_opus":0.03303958857861965,"score_gpt":0.40331211672551653,"score_spread":0.3702725281468969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390913863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75465935,0.019794034,0.0008873997,0.17728199,0.0017638721,0.00007341187,0.00024343604,0.00003472954,0.04526166],"genre_scores_gemma":[0.97083884,0.0068157697,0.00040548015,0.020146718,0.0005534693,0.000016508782,0.000040743205,0.00001056953,0.0011719208],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99569917,0.0029766662,0.00015990782,0.00013790638,0.00048536537,0.0005410489],"domain_scores_gemma":[0.99239045,0.0027858166,0.0011884092,0.00010350647,0.00079408975,0.0027377643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027872545,0.00020343317,0.00042350774,0.000518258,0.0053442544,0.0033864358,0.00044334185,0.0023046723,0.004194722],"category_scores_gemma":[0.009852256,0.00025154868,0.0006032029,0.0005106722,0.0023516382,0.0030886433,0.0031757986,0.004227521,0.00035037563],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035504397,0.0011432648,0.21123205,0.0018828589,0.0004101659,0.028820561,0.5404047,0.0005263323,0.00159879,0.010469926,0.07915642,0.12399992],"study_design_scores_gemma":[0.00008609326,0.0009927506,0.06485334,0.0028215102,0.00018089422,0.03040969,0.77530855,0.0005435956,0.00033965477,0.0035361275,0.12072526,0.00020253628],"about_ca_topic_score_codex":0.0040839077,"about_ca_topic_score_gemma":0.009692169,"teacher_disagreement_score":0.0053442544,"about_ca_system_score_codex":0.001755876,"about_ca_system_score_gemma":0.0026726488,"threshold_uncertainty_score":0.014740527},"labels":[],"label_agreement":null},{"id":"W4390945704","doi":"10.1007/s13300-023-01527-w","title":"Emotional, Psychological, and Social Well-being Experience of Long-Term Living with Type 1 Diabetes Mellitus: A Patient–Psychiatrist–Endocrinologist Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Mental Health Association; Trillium Health Centre; University of Toronto","funders":"","keywords":"Quality of life (healthcare); Medicine; Denial; Mental health; Anxiety; Distress; Perspective (graphical); Type 1 diabetes; Stressor; Psychiatry; Depression (economics); Anger; Clinical psychology; Psychology; Diabetes mellitus; Psychotherapist; Nursing","score_opus":0.022890172114547164,"score_gpt":0.329286928443934,"score_spread":0.3063967563293868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390945704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51072824,0.046695568,0.0017050789,0.3942426,0.005858342,0.00009994099,0.00026617476,0.000038212245,0.040365875],"genre_scores_gemma":[0.9067406,0.03292715,0.0012018495,0.052905697,0.0022354156,0.00007084602,0.00009464274,0.000019433517,0.0038043975],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99798584,0.0012475696,0.00009806729,0.000089510395,0.0002582623,0.00032072334],"domain_scores_gemma":[0.9973508,0.0006664297,0.00025296595,0.00002840032,0.0003999604,0.0013014487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021068237,0.0003020741,0.00057268166,0.00051523204,0.0037109938,0.003401607,0.0006046356,0.002032797,0.0029043134],"category_scores_gemma":[0.0033941483,0.00018930092,0.00053212914,0.00047172306,0.0025531214,0.0026571634,0.0032447942,0.0066959877,0.00042345445],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024214735,0.0007614757,0.08103941,0.002035,0.00024829124,0.020192279,0.6445147,0.00038027394,0.003537517,0.013247349,0.108376235,0.1254254],"study_design_scores_gemma":[0.00003203511,0.00066684466,0.046911284,0.0022268768,0.00009045484,0.015591323,0.79317325,0.0003085831,0.0002911208,0.002623139,0.13792725,0.00015790973],"about_ca_topic_score_codex":0.0039818897,"about_ca_topic_score_gemma":0.0104787825,"teacher_disagreement_score":0.0039818897,"about_ca_system_score_codex":0.0016201825,"about_ca_system_score_gemma":0.0022322587,"threshold_uncertainty_score":0.011755347},"labels":[],"label_agreement":null},{"id":"W4391716976","doi":"10.1007/s13300-024-01535-4","title":"Identifying Ontarians with Type 2 Diabetes Mellitus in Administrative Data: A Comparison of Two Case Definitions","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"Novo Nordisk Canada","keywords":"Medicine; Cohort; Diabetes mellitus; Type 2 diabetes; Cohort study; Internal medicine; Pediatrics; Endocrinology","score_opus":0.5785092043281571,"score_gpt":0.5364634391774333,"score_spread":0.04204576515072378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391716976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918887,0.001305355,0.0026397922,0.0002872318,0.000049490267,0.00043640868,0.0015156483,0.000017067874,0.0018603365],"genre_scores_gemma":[0.9940749,0.00046841928,0.002268829,0.00016790448,0.00003850671,0.00025858358,0.00258201,0.000008037647,0.0001327945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97235346,0.012747933,0.0036084491,0.0027352744,0.0070127817,0.0015420183],"domain_scores_gemma":[0.94930696,0.018256553,0.020269888,0.004443837,0.006609642,0.0011131981],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021967707,0.00055143645,0.00074095634,0.0038319137,0.0011070879,0.0023770954,0.0020840107,0.0006860933,0.00055789633],"category_scores_gemma":[0.0660338,0.0005372267,0.0016945177,0.0036745316,0.0009985518,0.001476869,0.002523122,0.0005880343,0.000104059014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021739179,0.000027595492,0.99462813,0.00006853308,0.00019047191,0.00004261554,0.00051095284,0.000121316225,0.00006444162,0.00013227039,0.00030856612,0.0036878935],"study_design_scores_gemma":[0.000052528725,0.00015344037,0.9947548,0.000120801145,0.00023268472,0.00016640854,0.0014943029,0.0016968305,0.00018964494,0.00012803024,0.000990057,0.000020554013],"about_ca_topic_score_codex":0.18414024,"about_ca_topic_score_gemma":0.28133187,"teacher_disagreement_score":0.8158598,"about_ca_system_score_codex":0.005931235,"about_ca_system_score_gemma":0.0041512083,"threshold_uncertainty_score":0.36613685},"labels":[],"label_agreement":null},{"id":"W4393114796","doi":"10.1007/s13300-024-01549-y","title":"Validity of Montreal Cognitive Assessment to Detect Cognitive Impairment in Individuals with Type 2 Diabetes","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Indian Council of Medical Research","keywords":"Montreal Cognitive Assessment; Medicine; Cognitive impairment; Type 2 diabetes; Diabetes mellitus; Cognition; Gerontology; Psychiatry; Endocrinology","score_opus":0.02273430786966418,"score_gpt":0.3412973756145462,"score_spread":0.318563067744882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393114796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97281206,0.00562822,0.0024606169,0.00042410762,0.00020455138,0.00073479995,0.0032645802,0.00011847471,0.014352569],"genre_scores_gemma":[0.99486417,0.00059014553,0.0020248264,0.00017400247,0.000046252677,0.00025810392,0.0013962379,0.0000115732855,0.00063471374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99608827,0.0010472392,0.00052505446,0.0005938414,0.0014806432,0.00026501316],"domain_scores_gemma":[0.9939991,0.0016484383,0.0020270576,0.00032101735,0.0014720209,0.0005323017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007410663,0.0008944741,0.000859989,0.0035519674,0.0007629876,0.0012008522,0.0012560729,0.0008339027,0.0010439263],"category_scores_gemma":[0.016522218,0.00039431016,0.0022078059,0.001465207,0.0006587018,0.0008636831,0.0013560925,0.0009993035,0.0003313794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028844783,0.00012182776,0.9882488,0.000063131236,0.00047582414,0.000054165863,0.0001437593,0.0004092838,0.00014408925,0.00013609599,0.0008319996,0.009082605],"study_design_scores_gemma":[0.000049709754,0.00023151634,0.9962658,0.00007382128,0.00010367904,0.00016900404,0.000089717585,0.0015516976,0.00014371434,0.00030323927,0.0009969148,0.000021171056],"about_ca_topic_score_codex":0.044221498,"about_ca_topic_score_gemma":0.047027092,"teacher_disagreement_score":0.044221498,"about_ca_system_score_codex":0.0012942652,"about_ca_system_score_gemma":0.0013163427,"threshold_uncertainty_score":0.087928176},"labels":[],"label_agreement":null},{"id":"W4399544780","doi":"10.1007/s13300-024-01603-9","title":"Perspectives and Behaviors of People with Diabetes toward Time in Range and Glucose Control in Diabetes Management: An Online Survey","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trillium Health Centre","funders":"Novo Nordisk","keywords":"Diabetes mellitus; Medicine; Diabetes management; Diabetes control; Control (management); Gerontology; Endocrinology; Type 2 diabetes; Artificial intelligence; Computer science","score_opus":0.01734584637604032,"score_gpt":0.267933354979457,"score_spread":0.25058750860341666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399544780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978517,0.000118686905,0.000092511764,0.00020381597,0.0000079491765,0.000032965298,0.00055294007,0.0000031450563,0.001136288],"genre_scores_gemma":[0.9981396,0.0002981554,0.0003131742,0.00030804027,0.000013742943,0.000075862205,0.00038780985,0.0000016567285,0.00046207913],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993486,0.00025441422,0.000091864844,0.00005494275,0.00013794494,0.000112296344],"domain_scores_gemma":[0.9981616,0.00041562403,0.000727446,0.000052444135,0.00026330148,0.0003796165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011026169,0.0001371778,0.0002022505,0.0005795857,0.00041331514,0.0006792448,0.00014404379,0.00033261284,0.0022177093],"category_scores_gemma":[0.002495087,0.0001574807,0.00038246324,0.00066262006,0.00016227496,0.0006751965,0.0006318977,0.00047286885,0.0004124612],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049659764,0.00023709837,0.9803058,0.00011558415,0.000035575187,0.00011530363,0.0050718314,0.0000378077,0.00034110856,0.000028316716,0.0005370773,0.01312494],"study_design_scores_gemma":[0.000013609217,0.00036727334,0.9767942,0.000102160084,0.0000273937,0.00036571277,0.019346684,0.00016695372,0.00014868529,0.000041920535,0.002608902,0.000016571381],"about_ca_topic_score_codex":0.0028128403,"about_ca_topic_score_gemma":0.0032185854,"teacher_disagreement_score":0.0028128403,"about_ca_system_score_codex":0.00021767452,"about_ca_system_score_gemma":0.00025678208,"threshold_uncertainty_score":0.00741899},"labels":[],"label_agreement":null},{"id":"W4400789217","doi":"10.1007/s13300-024-01606-6","title":"Epidemiology and Burden of Peripheral Artery Disease in People With Type 2 Diabetes: A Systematic Literature Review","year":2024,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"Novo Nordisk","keywords":"Medicine; Epidemiology; Diabetes mellitus; Type 2 diabetes; Disease; Systematic review; Arterial disease; Intensive care medicine; MEDLINE; Internal medicine; Vascular disease; Endocrinology","score_opus":0.0265531670890875,"score_gpt":0.31857271021602207,"score_spread":0.29201954312693457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400789217","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013862617,0.99722666,0.0000825193,0.00020681464,0.0000715531,0.0001551797,0.00069041806,0.000006151927,0.0001744794],"genre_scores_gemma":[0.010587812,0.9880233,0.00034968313,0.00029741536,0.000056685578,0.00026271958,0.00035324288,0.0000033579856,0.000065678214],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99421185,0.0014850863,0.0026541962,0.00048020642,0.0010016535,0.00016693222],"domain_scores_gemma":[0.976716,0.016185068,0.004490406,0.00029225633,0.0020527388,0.00026363306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056954287,0.0012515605,0.007490135,0.0151093835,0.000565681,0.0023643498,0.0012817889,0.0014649978,0.003402986],"category_scores_gemma":[0.027672792,0.0011188105,0.007148889,0.01745276,0.000621567,0.0018697378,0.0015720078,0.0010194761,0.0002471756],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013826048,0.000013941551,0.002574479,0.9545704,0.009652962,0.0001301817,0.00023291873,0.00010047428,0.00007540758,0.0001430039,0.0017996472,0.03056836],"study_design_scores_gemma":[0.00015762543,0.00014044881,0.012559513,0.90312755,0.06888347,0.0006671382,0.00036010347,0.00009672191,0.00007949848,0.0002405227,0.013639483,0.000047984682],"about_ca_topic_score_codex":0.013811567,"about_ca_topic_score_gemma":0.031057853,"teacher_disagreement_score":0.0151093835,"about_ca_system_score_codex":0.0030057502,"about_ca_system_score_gemma":0.009934073,"threshold_uncertainty_score":0.03012067},"labels":[],"label_agreement":null},{"id":"W4401163838","doi":"10.1007/s13300-024-01628-0","title":"Medication-Induced Hyperglycemia and Diabetes Mellitus: A Review of Current Literature and Practical Management Strategies","year":2024,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"AstraZeneca; Amgen","keywords":"Medicine; Diabetes mellitus; Intensive care medicine; Endocrinology","score_opus":0.04936297382883068,"score_gpt":0.383220159848608,"score_spread":0.3338571860197773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401163838","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007005189,0.9991253,0.000046144978,0.00021988603,0.00012466872,0.0000049844843,0.000017769857,0.0000035773526,0.00038766713],"genre_scores_gemma":[0.00031812026,0.9992217,0.000103798106,0.00013197625,0.000101639045,0.000004542162,0.000018794432,5.645784e-7,0.0000988448],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9995844,0.000074524105,0.00011904672,0.000059826492,0.00013319116,0.000029018682],"domain_scores_gemma":[0.9989158,0.0006824611,0.00018352782,0.000017725748,0.00015698161,0.000043618584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007850635,0.0009914156,0.0015062712,0.0041830065,0.00038526635,0.0012543143,0.0010037515,0.0010535914,0.0046725036],"category_scores_gemma":[0.0021428578,0.00037112512,0.0012231201,0.004351665,0.0004647552,0.0016240337,0.0007370042,0.0015145108,0.0009838613],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010199242,0.0000958439,0.00053676846,0.08807413,0.00027224084,0.00036662494,0.00015328392,0.00032631736,0.00043162037,0.002686695,0.035704367,0.87125015],"study_design_scores_gemma":[0.000040890463,0.00016109011,0.0032480995,0.072113246,0.0010541631,0.003906463,0.0002491163,0.00019099152,0.00022893207,0.0030963093,0.91566074,0.00004996196],"about_ca_topic_score_codex":0.0023748023,"about_ca_topic_score_gemma":0.0041250126,"teacher_disagreement_score":0.0046725036,"about_ca_system_score_codex":0.00078463525,"about_ca_system_score_gemma":0.0023984234,"threshold_uncertainty_score":0.01563108},"labels":[],"label_agreement":null},{"id":"W4404202498","doi":"10.1007/s13300-024-01659-7","title":"Cardiovascular, Metabolic, and Safety Outcomes with Semaglutide by Baseline Age: Post Hoc Analysis of SUSTAIN 6 and PIONEER 6","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ted Rogers Centre for Heart Research; University of Toronto","funders":"Novo Nordisk","keywords":"Semaglutide; Post-hoc analysis; Medicine; Baseline (sea); Diabetes mellitus; Post hoc; Internal medicine; Type 2 diabetes; Endocrinology; Liraglutide","score_opus":0.005565111311902527,"score_gpt":0.23040575488444723,"score_spread":0.2248406435725447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404202498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993895,0.002280375,0.00060704513,0.00007620426,0.00009613152,0.0003868101,0.0016059277,0.000055009084,0.0009974827],"genre_scores_gemma":[0.99138886,0.0008062316,0.001313351,0.0002289903,0.00018373446,0.00089588977,0.0025175249,0.000050540377,0.00261479],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9975327,0.0012955113,0.00018167119,0.00034843563,0.00034036493,0.0003013267],"domain_scores_gemma":[0.9966151,0.0017078778,0.00057514175,0.00047851843,0.00033970212,0.00028374945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005950612,0.0010545683,0.0049096695,0.00040295706,0.00020380381,0.0007244366,0.00054347515,0.00069174846,0.0027630946],"category_scores_gemma":[0.0042217616,0.00034092966,0.006108429,0.000508789,0.0004067658,0.000791073,0.0005296089,0.0014162497,0.0002323855],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.938737,0.0014733002,0.016717909,0.00072751153,0.017437639,0.00013215604,0.000102695965,0.0015557137,0.0067414306,0.00013366975,0.001283516,0.014957515],"study_design_scores_gemma":[0.12615545,0.36489823,0.42189774,0.0001504745,0.060334228,0.0002816359,0.00020919784,0.008528011,0.010378353,0.00083727116,0.006146208,0.00018332481],"about_ca_topic_score_codex":0.0010749681,"about_ca_topic_score_gemma":0.0018865821,"teacher_disagreement_score":0.005950612,"about_ca_system_score_codex":0.0003663019,"about_ca_system_score_gemma":0.0008812601,"threshold_uncertainty_score":0.03147024},"labels":[],"label_agreement":null},{"id":"W4404338793","doi":"10.1007/s13300-024-01668-6","title":"Oral Semaglutide Use in Type 2 Diabetes: A Pooled Analysis of Clinical and Patient-Reported Outcomes from Seven PIONEER REAL Prospective Real-World Studies","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Novo Nordisk","keywords":"Semaglutide; Medicine; Type 2 diabetes; Diabetes mellitus; Pooled analysis; Prospective cohort study; Meta-analysis; Pediatrics; Internal medicine; Endocrinology","score_opus":0.061546688346997835,"score_gpt":0.3677193614407986,"score_spread":0.30617267309380075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404338793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7404199,0.23983134,0.0046347855,0.00026153596,0.0002847938,0.00061626814,0.012564972,0.00015663031,0.0012298223],"genre_scores_gemma":[0.9751824,0.015848793,0.0019819438,0.00023224817,0.00012845451,0.00069968234,0.00567508,0.0000449524,0.00020644332],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9807575,0.010887882,0.0039867065,0.0022619588,0.0017764411,0.00032954206],"domain_scores_gemma":[0.9776564,0.010880655,0.0072177523,0.0023415925,0.0015873922,0.00031622368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019948356,0.0018463369,0.0063973586,0.0038178822,0.00030659628,0.0024180643,0.0008011356,0.0012241855,0.00086588453],"category_scores_gemma":[0.0187027,0.0009318352,0.016280744,0.0053151846,0.0004329865,0.0007771819,0.0013762382,0.0005650489,0.0001401614],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030435966,0.00009039348,0.19187555,0.009343911,0.7512202,0.00020891217,0.00013202504,0.0017494139,0.0010376843,0.000064245694,0.00086660264,0.012975073],"study_design_scores_gemma":[0.0046395045,0.0022795436,0.33543092,0.00104707,0.65141547,0.00041372553,0.00022499947,0.0017164203,0.0006112065,0.00022051056,0.0018785648,0.0001221044],"about_ca_topic_score_codex":0.002260857,"about_ca_topic_score_gemma":0.0033154371,"teacher_disagreement_score":0.019948356,"about_ca_system_score_codex":0.00053871656,"about_ca_system_score_gemma":0.0006778493,"threshold_uncertainty_score":0.105498195},"labels":[],"label_agreement":null},{"id":"W4405458940","doi":"10.1007/s13300-024-01677-5","title":"Cost-Effectiveness of FreeStyle Libre for Glucose Self-Management Among People with Diabetes Mellitus: A Canadian Private Payer Perspective","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Research","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); EVERSANA (Canada); Western University","funders":"Abbott Diabetes Care","keywords":"Medicine; Glycated hemoglobin; Diabetes mellitus; Type 1 diabetes; Type 2 Diabetes Mellitus; Hypoglycemia; Insulin; Blood Glucose Self-Monitoring; Diabetic ketoacidosis; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Continuous glucose monitoring","score_opus":0.015296523712522013,"score_gpt":0.28376256865933874,"score_spread":0.26846604494681675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405458940","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9024054,0.016373644,0.00468448,0.007159346,0.00015594692,0.0006822644,0.015203748,0.000109475484,0.053225618],"genre_scores_gemma":[0.9938066,0.001747327,0.001378706,0.00024511706,0.000027546994,0.00004609946,0.0012376952,0.000010714454,0.0015000964],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9972211,0.00088397885,0.000091263144,0.00020225998,0.0008088131,0.0007925182],"domain_scores_gemma":[0.9964216,0.0018013503,0.00036869562,0.00010704711,0.00087857223,0.00042282918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028152862,0.0007034534,0.0010521199,0.0016856093,0.0008822196,0.0026550512,0.0015344087,0.0011456781,0.0032144806],"category_scores_gemma":[0.009213496,0.00041428118,0.0023174314,0.0024899975,0.00064312544,0.00077566446,0.0008507104,0.0009260085,0.00014297219],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006419219,0.0006541486,0.17609367,0.0018788892,0.0035751034,0.0007970355,0.00069908233,0.6296358,0.0013057222,0.04895457,0.019461354,0.11052545],"study_design_scores_gemma":[0.0011281177,0.001657233,0.24502747,0.0008474203,0.0049970346,0.0006024241,0.0022246384,0.7122198,0.0009507653,0.009144175,0.02081196,0.0003889286],"about_ca_topic_score_codex":0.9564205,"about_ca_topic_score_gemma":0.9423864,"teacher_disagreement_score":0.05904744,"about_ca_system_score_codex":0.05904744,"about_ca_system_score_gemma":0.042406753,"threshold_uncertainty_score":0.42842114},"labels":[],"label_agreement":null},{"id":"W4405466175","doi":"10.1007/s13300-024-01671-x","title":"Clinical Profile and Treatment Adherence in Patients with Type 2 Diabetes and Chronic Kidney Disease Who Initiate an SGLT2 Inhibitor: A Multi-cohort Study","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Kidney disease; Cohort; Disease; Internal medicine; Cohort study; Intensive care medicine; Endocrinology","score_opus":0.02515344726231022,"score_gpt":0.3114057257762158,"score_spread":0.28625227851390556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405466175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99844897,0.00014934571,0.0000815974,0.000045570854,0.0000079343035,0.000035596815,0.0010208273,0.000002406205,0.00020770181],"genre_scores_gemma":[0.9982541,0.00008705497,0.00015056418,0.00007214007,0.000015736305,0.000051365616,0.0012213553,0.0000039267857,0.00014373033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841106,0.0003984323,0.00022278247,0.000509181,0.00023540508,0.00022301759],"domain_scores_gemma":[0.99749196,0.0002966701,0.00091889256,0.00045941302,0.00031399104,0.00051894365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017722169,0.00041310853,0.0007805043,0.0009217251,0.0010565348,0.0014469946,0.0007493218,0.00086145865,0.0014136544],"category_scores_gemma":[0.003735248,0.00063641375,0.0015118372,0.0016587188,0.00028519827,0.0011138306,0.0012072019,0.0013430932,0.0003643425],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044803866,0.00017403759,0.9980368,0.000012383078,0.0002988075,0.000049075705,0.00014878929,0.000030377614,0.00010405698,0.000014266079,0.00015012051,0.0005332286],"study_design_scores_gemma":[0.00009288602,0.0002960674,0.99815196,0.000014039,0.00019968681,0.00020555276,0.0003055364,0.0004113026,0.00003973529,0.000022756727,0.00024647592,0.000014015615],"about_ca_topic_score_codex":0.01062601,"about_ca_topic_score_gemma":0.010306539,"teacher_disagreement_score":0.01062601,"about_ca_system_score_codex":0.000557044,"about_ca_system_score_gemma":0.0005058617,"threshold_uncertainty_score":0.021128356},"labels":[],"label_agreement":null},{"id":"W4405657525","doi":"10.1007/s13300-024-01674-8","title":"A Bioequivalence Study of Two Formulations of Oral Semaglutide in Healthy Participants","year":2024,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Altasciences (Canada)","funders":"Novo Nordisk","keywords":"Bioequivalence; Semaglutide; Medicine; Cmax; Pharmacokinetics; Crossover study; Confidence interval; Dosing; Pharmacology; Oral administration; Internal medicine; Type 2 diabetes; Diabetes mellitus; Endocrinology; Placebo; Alternative medicine","score_opus":0.07649554360568715,"score_gpt":0.3842856745036573,"score_spread":0.30779013089797014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405657525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99598217,0.0005716899,0.00089535257,0.000052054373,0.0000760763,0.0015240631,0.0002921441,0.000030971827,0.0005753259],"genre_scores_gemma":[0.99392843,0.0002485592,0.0021292365,0.000206408,0.00006269242,0.0021287836,0.00033972898,0.00001603111,0.000940078],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9973126,0.0014606131,0.00018658173,0.0005460669,0.00035546653,0.00013867403],"domain_scores_gemma":[0.99842703,0.00046039151,0.0003157457,0.0002502487,0.00030841175,0.00023825534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005108024,0.000961479,0.0016825902,0.00030511495,0.00054962665,0.00065186096,0.00048504645,0.00149948,0.0030812584],"category_scores_gemma":[0.005640333,0.0006240812,0.001141285,0.00023909935,0.00072007324,0.0008902484,0.0004711436,0.00109303,0.00069122395],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.83529174,0.03409842,0.009161522,0.0011280148,0.0023846868,0.00014486033,0.0021255384,0.0006914875,0.060318008,0.0005781271,0.001233743,0.052843794],"study_design_scores_gemma":[0.1543125,0.75485957,0.071685985,0.00008688892,0.0026766623,0.00026146162,0.00042930007,0.0029394592,0.007229311,0.0006472715,0.004705656,0.00016590294],"about_ca_topic_score_codex":0.0009003982,"about_ca_topic_score_gemma":0.00085370353,"teacher_disagreement_score":0.005108024,"about_ca_system_score_codex":0.0004572682,"about_ca_system_score_gemma":0.0007656563,"threshold_uncertainty_score":0.027014136},"labels":[],"label_agreement":null},{"id":"W4408621302","doi":"10.1007/s13300-025-01717-8","title":"Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Type 2 diabetes; Diabetes mellitus; Agonist; Kidney disease; Disease; Cohort; Internal medicine; Receptor; Endocrinology","score_opus":0.017642522699609454,"score_gpt":0.31012728479725227,"score_spread":0.2924847620976428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408621302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966491,0.00015675122,0.00008705238,0.000055668956,0.0000069275216,0.000028521647,0.0027730896,0.000003208884,0.00023972108],"genre_scores_gemma":[0.9963845,0.00010192213,0.00024925612,0.00009706807,0.0000096711265,0.0000712528,0.002897427,0.000005353642,0.00018359163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849796,0.00041774797,0.00018525541,0.00055336487,0.00018075993,0.00016489282],"domain_scores_gemma":[0.99783117,0.00019915201,0.0010452546,0.0004314214,0.00019170553,0.00030133926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021193356,0.00037543554,0.0005203992,0.0008019242,0.00070531317,0.0010517576,0.0007288053,0.0004954221,0.0011066314],"category_scores_gemma":[0.0030660743,0.00043876815,0.0008593078,0.001940699,0.00030839452,0.0006522388,0.0011198709,0.00063195283,0.00028850383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002040106,0.00003808515,0.998858,0.0000073118667,0.00013396514,0.00002801573,0.00008738387,0.000023092496,0.00008593423,0.000009200421,0.00015542393,0.00036965444],"study_design_scores_gemma":[0.000042057,0.00009188126,0.99875057,0.000011726384,0.00011558084,0.00016389575,0.00023803882,0.000186547,0.000039486484,0.000015937481,0.00033756884,0.0000067573897],"about_ca_topic_score_codex":0.0137645975,"about_ca_topic_score_gemma":0.016223362,"teacher_disagreement_score":0.0137645975,"about_ca_system_score_codex":0.0005341751,"about_ca_system_score_gemma":0.0005956741,"threshold_uncertainty_score":0.027368963},"labels":[],"label_agreement":null},{"id":"W4408921665","doi":"10.1007/s13300-025-01725-8","title":"Systematic Literature Review of the Impact of Type 2 Diabetes and Heart Failure Guideline Adherence on Clinical and Economic Outcomes","year":2025,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; MEDLINE; Intensive care medicine; Guideline; Disease management; Type 2 diabetes; Systematic review; Diabetes mellitus; Clinical trial; Disease; Internal medicine; Pathology","score_opus":0.05839507894475807,"score_gpt":0.4296025219781489,"score_spread":0.3712074430333908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408921665","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033268644,0.9927227,0.0002575651,0.0005541198,0.00017361782,0.00092005136,0.0013890711,0.000013174452,0.00064277614],"genre_scores_gemma":[0.04545134,0.94913256,0.0013833753,0.0009313521,0.00015204455,0.0019507462,0.0008233801,0.0000100705,0.0001651691],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98334724,0.0063182665,0.006347625,0.0008915241,0.0027598871,0.00033544606],"domain_scores_gemma":[0.9315686,0.04886342,0.013776174,0.0007804231,0.004511439,0.00049981434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015867915,0.0012967223,0.008999316,0.011007179,0.00063300086,0.0029519869,0.0020812072,0.0017672115,0.005354337],"category_scores_gemma":[0.08017629,0.0009260275,0.007681662,0.01383169,0.0008962644,0.0020396837,0.0014815101,0.0011518626,0.00027455387],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017223328,0.000020916399,0.0014960028,0.9620802,0.01250588,0.000082236926,0.00015277092,0.00010238397,0.000048563998,0.000157061,0.0009819014,0.022199847],"study_design_scores_gemma":[0.00038853218,0.00022217949,0.008394717,0.89403415,0.087545075,0.00023665167,0.0002526154,0.00012184351,0.000098923454,0.0002650019,0.008404762,0.00003552652],"about_ca_topic_score_codex":0.012251843,"about_ca_topic_score_gemma":0.027494442,"teacher_disagreement_score":0.015867915,"about_ca_system_score_codex":0.0047873342,"about_ca_system_score_gemma":0.015472963,"threshold_uncertainty_score":0.08391857},"labels":[],"label_agreement":null},{"id":"W4411043752","doi":"10.1007/s13300-025-01750-7","title":"Outcomes in New User Cohorts of SGLT2 Inhibitors or GLP-1 Receptor Agonists with Type 2 Diabetes and Chronic Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Bayer","keywords":"Medicine; Kidney disease; Internal medicine; Renal function; Type 2 diabetes; Diabetes mellitus; Incidence (geometry); Heart failure; Endocrinology","score_opus":0.008517939849199086,"score_gpt":0.2554512744432463,"score_spread":0.2469333345940472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411043752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98996615,0.000528008,0.00027936924,0.00004069218,0.000017731922,0.000050551807,0.008567968,0.00000801074,0.00054156984],"genre_scores_gemma":[0.982015,0.0003222028,0.0004311626,0.00010017597,0.000029814964,0.00013046557,0.016444884,0.000009218944,0.00051706715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974989,0.0004961591,0.0004490579,0.0008815413,0.0004096892,0.00026467675],"domain_scores_gemma":[0.9959636,0.00042964006,0.002063872,0.0006937069,0.0004562617,0.00039289554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002603672,0.00036279354,0.00071456376,0.0013558626,0.0005971489,0.001307822,0.00073149434,0.000464646,0.0010082163],"category_scores_gemma":[0.0051572495,0.0005773074,0.0014065739,0.0022063712,0.00026114003,0.0008665316,0.0014604242,0.0009407552,0.00026759735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002902792,0.00002766108,0.99819666,0.000020133175,0.00026330972,0.00004140186,0.0000941301,0.00006545421,0.000066885164,0.000028161789,0.00023348602,0.0006725302],"study_design_scores_gemma":[0.000038160844,0.00010517562,0.9981504,0.000017151968,0.00015455142,0.00022453004,0.00015965903,0.00027008928,0.0000671799,0.00003891435,0.0007641127,0.000009987191],"about_ca_topic_score_codex":0.01772968,"about_ca_topic_score_gemma":0.01711996,"teacher_disagreement_score":0.01772968,"about_ca_system_score_codex":0.00060332805,"about_ca_system_score_gemma":0.00076594454,"threshold_uncertainty_score":0.03525293},"labels":[],"label_agreement":null},{"id":"W4412512272","doi":"10.1007/s13300-025-01772-1","title":"Real-World Effectiveness of My Dose Coach™-Assisted Basal Insulin Titration in People with Type 2 Diabetes in Saudi Arabia and Kuwait","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Sanofi","keywords":"Medicine; Basal insulin; Type 2 diabetes; Diabetes mellitus; Basal (medicine); Insulin; Internal medicine; Endocrinology","score_opus":0.02097535155161321,"score_gpt":0.3613597529609785,"score_spread":0.34038440140936527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412512272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99962854,0.00009685552,0.0000107592095,0.000027288235,0.0000022221525,0.0000054138277,0.00014708375,9.375122e-7,0.000080767524],"genre_scores_gemma":[0.9996369,0.000078625,0.000039392682,0.000026099075,0.000003057249,0.000009657551,0.00016614051,7.9978474e-7,0.000039259914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873847,0.00054811925,0.00017644798,0.00018388362,0.00016004419,0.00019305274],"domain_scores_gemma":[0.99650794,0.00068918534,0.0016393161,0.00015802938,0.00052738644,0.0004780013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020712733,0.00044686155,0.0004611098,0.00056151993,0.00056976965,0.0010989619,0.0004932029,0.0005884321,0.0006977092],"category_scores_gemma":[0.0052687335,0.00028305582,0.0008380417,0.0009697109,0.00040303599,0.00056646386,0.00083921803,0.0005542337,0.00015347998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000718509,0.00015347537,0.99474066,0.0000402824,0.000107676555,0.000059426373,0.0006781869,0.00010299536,0.000096338,0.000012399211,0.00009231326,0.003197727],"study_design_scores_gemma":[0.000046319197,0.0004208112,0.99661994,0.000030508416,0.0001047461,0.00010847007,0.001574746,0.00087215693,0.00006877191,0.000010285653,0.0001268412,0.000016398599],"about_ca_topic_score_codex":0.11080331,"about_ca_topic_score_gemma":0.08486109,"teacher_disagreement_score":0.11080331,"about_ca_system_score_codex":0.001740591,"about_ca_system_score_gemma":0.0011540157,"threshold_uncertainty_score":0.22031671},"labels":[],"label_agreement":null},{"id":"W4413335991","doi":"10.1007/s13300-025-01779-8","title":"Quantifying Patient Preferences for Basal Insulin Treatments in Adults Living with Type 2 Diabetes: A Discrete Choice Experiment in Canada, Spain, France, and Japan","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk","keywords":"Medicine; Type 2 diabetes; Basal insulin; Diabetes mellitus; Basal (medicine); Gerontology; Endocrinology","score_opus":0.03772920654805889,"score_gpt":0.2218588422073667,"score_spread":0.18412963565930782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413335991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981008,0.00008410317,0.0002522055,0.00009211267,0.000008536909,0.0005261244,0.00022641689,0.0000028864943,0.0007067877],"genre_scores_gemma":[0.99367094,0.00026541617,0.003002236,0.0003807582,0.000012484973,0.0011036759,0.0004874302,0.0000042074603,0.0010728217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99612385,0.0021109688,0.00025727475,0.00035505535,0.00059470115,0.0005581141],"domain_scores_gemma":[0.98908514,0.0058990684,0.0010481912,0.00039605168,0.0023340993,0.0012374291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008814446,0.0005884492,0.00091390894,0.00050241646,0.002323618,0.0015088544,0.00064767414,0.0010353841,0.002341901],"category_scores_gemma":[0.0101624895,0.0004187326,0.0012440496,0.001102211,0.0016762224,0.00047324714,0.00085470226,0.00095652987,0.00016667487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06847508,0.036806095,0.7126813,0.0019261405,0.0012581208,0.0015308919,0.04455617,0.010345586,0.009502493,0.003004109,0.005101973,0.104812],"study_design_scores_gemma":[0.014644213,0.031167587,0.8586186,0.00068279024,0.0008605646,0.0003193122,0.049513247,0.02705723,0.0034670252,0.0013009756,0.011768499,0.00059991586],"about_ca_topic_score_codex":0.77950436,"about_ca_topic_score_gemma":0.8280495,"teacher_disagreement_score":0.77950436,"about_ca_system_score_codex":0.013412523,"about_ca_system_score_gemma":0.021700386,"threshold_uncertainty_score":0.44358832},"labels":[],"label_agreement":null},{"id":"W4413981095","doi":"10.1007/s13300-025-01783-y","title":"Perceptions of the Benefits and Risks of Novel Therapies for Type 1 Diabetes: A Qualitative Study","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Pancreatic function and diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Type 2 diabetes; Disease; Diabetes mellitus; Type 1 diabetes; Qualitative research; MEDLINE; Family medicine; Gerontology; Pathology","score_opus":0.11153474332770745,"score_gpt":0.4020986712141507,"score_spread":0.29056392788644325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413981095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918543,0.00076405716,0.0014167827,0.002208977,0.00006189161,0.00024263967,0.00016737003,0.000009434081,0.0032745958],"genre_scores_gemma":[0.99450856,0.0012461278,0.00085786614,0.0011693417,0.000023793338,0.00045674975,0.00006426836,0.000013383395,0.0016598868],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9919382,0.005927037,0.0002226032,0.0003763581,0.0005192528,0.0010165009],"domain_scores_gemma":[0.9775324,0.017089102,0.0014390782,0.00029997015,0.0015030152,0.0021364638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015603776,0.0005914095,0.00077818055,0.0012393798,0.007524445,0.003451002,0.0014130204,0.0017214475,0.0038961582],"category_scores_gemma":[0.017098457,0.00069854385,0.00054311083,0.0011974546,0.005879296,0.0041589206,0.004394043,0.0030359076,0.00037638808],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035989557,0.00005137038,0.0028725835,0.00015727825,0.0000036699996,0.00037550722,0.9933427,0.000021330448,0.0003352798,0.00044438688,0.00026164352,0.0020982935],"study_design_scores_gemma":[0.0000048896036,0.000047408277,0.0008489216,0.00016625429,0.0000031251948,0.00011842314,0.99614894,0.00003723291,0.000089016765,0.00011740848,0.0024110456,0.0000073911337],"about_ca_topic_score_codex":0.009093781,"about_ca_topic_score_gemma":0.0115107745,"teacher_disagreement_score":0.015603776,"about_ca_system_score_codex":0.004636744,"about_ca_system_score_gemma":0.0049570655,"threshold_uncertainty_score":0.08252168},"labels":[],"label_agreement":null},{"id":"W4414361910","doi":"10.1007/s13300-025-01796-7","title":"Pillar Risk-Based Treatment for Chronic Kidney Disease in People With Type 2 Diabetes: A Narrative Review","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; Trillium Health Centre; University of Toronto","funders":"Bayer","keywords":"Kidney disease; Tolerability; Context (archaeology); Disease; Narrative review; Diabetes mellitus; Type 2 diabetes","score_opus":0.011106669528985659,"score_gpt":0.2817078758975569,"score_spread":0.27060120636857127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414361910","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000111459696,0.9979443,0.00011204362,0.00081783,0.000249216,0.000018404035,0.000042610347,0.0000049328064,0.0006992236],"genre_scores_gemma":[0.0009969858,0.997512,0.00026585962,0.0007625519,0.0002382934,0.000030491721,0.000043429412,0.0000020643863,0.00014844663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99935585,0.00019318257,0.0001580819,0.000080985876,0.00017662375,0.00003516298],"domain_scores_gemma":[0.99753845,0.0018025845,0.00034748376,0.00002713591,0.00023410325,0.00005016119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011494423,0.0006286857,0.0012977521,0.0016767668,0.00036433883,0.0014824275,0.0009864053,0.0012105717,0.004358478],"category_scores_gemma":[0.0051777796,0.00024018488,0.0013670746,0.0018929077,0.00029823044,0.0012589673,0.0006883302,0.0016159135,0.00066791574],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012848515,0.00006348974,0.00042516858,0.19464403,0.00053065777,0.00019292506,0.00034655348,0.00030516225,0.00018313149,0.006585611,0.060291786,0.736303],"study_design_scores_gemma":[0.00008022661,0.00016960132,0.001949648,0.2278296,0.001963924,0.0015941742,0.00029620205,0.00027180862,0.00010182851,0.0030410527,0.7626495,0.000052479994],"about_ca_topic_score_codex":0.0022697828,"about_ca_topic_score_gemma":0.004025985,"teacher_disagreement_score":0.004358478,"about_ca_system_score_codex":0.00073101453,"about_ca_system_score_gemma":0.0024123702,"threshold_uncertainty_score":0.014580548},"labels":[],"label_agreement":null},{"id":"W4414523792","doi":"10.1007/s13300-025-01787-8","title":"Risk of Progression and Costs of Care for Patients with Type 2 Diabetes and Chronic Kidney Disease","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Chronic Kidney Disease and Diabetes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seven Oaks General Hospital","funders":"","keywords":"Type 2 diabetes; Kidney disease; Diabetes mellitus; Psychological intervention; Health care; Disease; Identification (biology)","score_opus":0.003586347832588687,"score_gpt":0.2541781987907708,"score_spread":0.2505918509581821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414523792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99331844,0.0010425146,0.00018066041,0.00051891047,0.000020889122,0.000020116115,0.003349522,0.0000088922125,0.0015401322],"genre_scores_gemma":[0.99654156,0.00052302104,0.00030446946,0.00009234792,0.000044292414,0.000023044526,0.0022894563,0.0000019496713,0.00017986771],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993444,0.00017431616,0.00008920757,0.000092334194,0.00022181147,0.00007790177],"domain_scores_gemma":[0.99781513,0.00027013916,0.0014876293,0.00006201095,0.00013599316,0.0002291391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006545681,0.00021073091,0.00028163265,0.00069243053,0.000386647,0.00064117863,0.00032676832,0.00030759172,0.002063854],"category_scores_gemma":[0.0035478973,0.0001414873,0.00048083437,0.001207865,0.00015465067,0.00042790727,0.0004504435,0.0007977012,0.00015059383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003869707,0.000016936561,0.9980046,0.0000144249025,0.00004706001,0.00002176318,0.00001336143,0.0000983867,0.000015781538,0.00003152059,0.0002560333,0.0014415106],"study_design_scores_gemma":[0.000008112666,0.000029041053,0.9983974,0.000029383464,0.000030091262,0.00023421504,0.00006100054,0.00071013044,0.000023874649,0.00009682881,0.0003760814,0.0000037021232],"about_ca_topic_score_codex":0.009687031,"about_ca_topic_score_gemma":0.010216299,"teacher_disagreement_score":0.009687031,"about_ca_system_score_codex":0.0006359039,"about_ca_system_score_gemma":0.00077646755,"threshold_uncertainty_score":0.0192613},"labels":[],"label_agreement":null},{"id":"W4414861752","doi":"10.1007/s13300-025-01802-y","title":"The Mechanisms of Inflammatory Factors and the Total Load of Cerebral Small Vessel Disease in Diabetic Retinopathy and Cognitive Impairment","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognitive impairment; Diabetes mellitus; Diabetic retinopathy; Disease; Retinopathy; Inflammation","score_opus":0.005877679644078948,"score_gpt":0.2288710978266742,"score_spread":0.22299341818259524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414861752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98837143,0.009634945,0.0006167802,0.0002527522,0.00001927917,0.000016758486,0.00022578478,0.000014908646,0.00084728375],"genre_scores_gemma":[0.9974105,0.0017206566,0.00044708434,0.00004052057,0.00006137088,0.000011111206,0.00010242415,0.0000013585737,0.00020502001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999645,0.00014632424,0.000034168617,0.000056472767,0.00006076454,0.00005728325],"domain_scores_gemma":[0.998544,0.00036909216,0.0007201517,0.000061752435,0.00014181994,0.00016326147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010837322,0.0005934092,0.0003674361,0.0012447644,0.00022988647,0.0007735065,0.0003181909,0.00036629682,0.0014254928],"category_scores_gemma":[0.001839743,0.00021673761,0.00059320446,0.00079273136,0.00035308482,0.00041003976,0.00031965825,0.00042323244,0.00015570047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005646397,0.00011453074,0.9858473,0.00009639646,0.00022818708,0.00019960711,0.000065258275,0.00022973388,0.00060994265,0.00009097088,0.000106663414,0.011846785],"study_design_scores_gemma":[0.000025852454,0.00025808616,0.99606305,0.000044315584,0.00023416933,0.00094760204,0.00010489204,0.0011295081,0.00043619695,0.00035449475,0.00039200694,0.0000099515455],"about_ca_topic_score_codex":0.0015388562,"about_ca_topic_score_gemma":0.0014939422,"teacher_disagreement_score":0.0015388562,"about_ca_system_score_codex":0.0002744306,"about_ca_system_score_gemma":0.00052859954,"threshold_uncertainty_score":0.005731404},"labels":[],"label_agreement":null},{"id":"W4415951323","doi":"10.1007/s13300-025-01804-w","title":"Insights into the Mechanism of Action of Tirzepatide: A Narrative Review","year":2025,"lang":"en","type":"review","venue":"Diabetes Therapy","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"Eli Lilly and Company","keywords":"Narrative review; Type 2 diabetes; Heart failure; Weight loss; Overweight; Glycemic; Mechanism (biology); Diabetes mellitus; Agonist","score_opus":0.04136549460698956,"score_gpt":0.3543042300904666,"score_spread":0.312938735483477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415951323","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000097296,0.99897563,0.00007395638,0.00020271442,0.00012035691,0.0000060689317,0.000026575335,0.0000048506467,0.0004925225],"genre_scores_gemma":[0.00049597456,0.9989121,0.00011321929,0.00014624275,0.00008665184,0.000006464309,0.000024208275,9.3009066e-7,0.00021430281],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998381,0.000029124927,0.00003704905,0.00003304229,0.000047047157,0.000015539279],"domain_scores_gemma":[0.99962485,0.00021578182,0.00006819188,0.000007816588,0.00006283089,0.000020582005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005278204,0.0008758628,0.0015230539,0.0022828782,0.00025069798,0.0012308769,0.0007798334,0.00087110745,0.0052469987],"category_scores_gemma":[0.0010180721,0.00025221103,0.00089654414,0.0018924555,0.00028994738,0.0012797925,0.00065456214,0.0013274387,0.0013595206],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001421483,0.00007985349,0.00018401499,0.0905556,0.00030327964,0.00034191762,0.00012717133,0.0003414207,0.0015940007,0.004120632,0.028142469,0.87406754],"study_design_scores_gemma":[0.0000377476,0.00016033453,0.0009418684,0.023961216,0.00070549746,0.0018313624,0.00011890815,0.00013395186,0.0004041117,0.0022811189,0.96939296,0.000030905565],"about_ca_topic_score_codex":0.000871357,"about_ca_topic_score_gemma":0.0015086333,"teacher_disagreement_score":0.0052469987,"about_ca_system_score_codex":0.00042523976,"about_ca_system_score_gemma":0.0012471005,"threshold_uncertainty_score":0.017552972},"labels":[],"label_agreement":null},{"id":"W4416776298","doi":"10.1007/s13300-025-01820-w","title":"Correction to: Quantifying Patient Preferences for Basal Insulin Treatments in Adults Living with Type 2 Diabetes: A Discrete Choice Experiment in Canada, Spain, France, and Japan","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Basal insulin; Type 2 diabetes; Diabetes mellitus; Basal (medicine); Type 1 diabetes","score_opus":0.03299408598097522,"score_gpt":0.22368033856492103,"score_spread":0.1906862525839458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416776298","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00088569557,0.0009147536,0.0015929631,0.04111089,0.9197556,0.00011079375,0.03235481,0.00062154967,0.0026529846],"genre_scores_gemma":[0.14802474,0.007503877,0.028383875,0.08585313,0.2879426,0.0029218104,0.053992607,0.004720504,0.38065684],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9942749,0.0014339043,0.0012411905,0.00077858526,0.0016568858,0.0006144467],"domain_scores_gemma":[0.8949707,0.035432693,0.0038583516,0.0076986062,0.05454547,0.0034941074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008136295,0.0022706988,0.0035634283,0.0036037946,0.0022753521,0.0035775425,0.0038449024,0.0053817234,0.24720253],"category_scores_gemma":[0.1588553,0.0010598757,0.0029054612,0.0056079538,0.0014633483,0.001881086,0.0021791293,0.0059900293,0.039680008],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000101137084,0.000008847262,0.00026092317,0.00021576529,0.000032277454,0.000070736285,0.000028221524,0.00011049173,0.000018912264,0.00059696246,0.9953656,0.003190094],"study_design_scores_gemma":[0.0019183214,0.000113211776,0.016595285,0.0021451986,0.00031383004,0.0006392541,0.0006951394,0.0042793904,0.0005938648,0.009947309,0.96238977,0.00036938774],"about_ca_topic_score_codex":0.10013249,"about_ca_topic_score_gemma":0.11867041,"teacher_disagreement_score":0.89986753,"about_ca_system_score_codex":0.005567073,"about_ca_system_score_gemma":0.011622253,"threshold_uncertainty_score":0.82697487},"labels":[],"label_agreement":null},{"id":"W4416776419","doi":"10.1007/s13300-025-01821-9","title":"Cost-effectiveness of Freestyle Libre Systems for People with Type 2 Diabetes Mellitus on Basal Insulin Therapy in the Netherlands: An Economic Evaluation from a Societal Perspective Within a Publicly Funded Healthcare System","year":2025,"lang":"en","type":"article","venue":"Diabetes Therapy","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"Abbott Diabetes Care","keywords":"Type 2 Diabetes Mellitus; Perspective (graphical); Healthcare system; Health care; Economic evaluation; Basal insulin; Type 2 diabetes","score_opus":0.05050749177980778,"score_gpt":0.33954838286225153,"score_spread":0.28904089108244374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416776419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826397,0.007739721,0.0025674417,0.00070206425,0.00009030313,0.0007078074,0.002330428,0.00001471067,0.0032078216],"genre_scores_gemma":[0.99571013,0.0015067585,0.0011767382,0.00008072245,0.000015101239,0.00040010962,0.0006988071,0.000008042503,0.00040354647],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99326766,0.0054468056,0.0003224669,0.00024605487,0.00041660215,0.00030058707],"domain_scores_gemma":[0.9927781,0.0055572493,0.0008293958,0.00015293217,0.00030899866,0.00037323555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076515954,0.0010710674,0.0017499946,0.0010655421,0.00026186305,0.0021746298,0.00086504215,0.0011011431,0.002437333],"category_scores_gemma":[0.019612264,0.00057599245,0.005155131,0.0014404875,0.0005605307,0.0014708092,0.0011249282,0.0009517391,0.0001167313],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.104601905,0.007241632,0.08558574,0.010133595,0.022924755,0.0014283042,0.0006169909,0.64103186,0.0014410429,0.009787608,0.004151359,0.11105527],"study_design_scores_gemma":[0.023542162,0.047950644,0.11584546,0.0026607788,0.024862872,0.0010054145,0.0021894486,0.7655064,0.0020719795,0.0068184305,0.0071132965,0.00043314445],"about_ca_topic_score_codex":0.022576818,"about_ca_topic_score_gemma":0.010823272,"teacher_disagreement_score":0.022576818,"about_ca_system_score_codex":0.007250212,"about_ca_system_score_gemma":0.0024090207,"threshold_uncertainty_score":0.05260414},"labels":[],"label_agreement":null}]}